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Klinefelter syndrome (KS) is the most frequent karyotype disorder of male reproductive
function. Since its original clinical description in 1942 and the identification of its
chromosomal basis 47,XXY in 1959, the typical KS phenotype has become well
recognized, but the mechanisms behind the testicular degeneration process have
remained unrevealed. The current study was undertaken to increase knowledge about
testicular function in adolescent KS boys. The purpose was to find targets for
therapeutic interventions, especially considering androgen deficiency and infertility.
This prospective study comprised a longitudinal follow-up of growth, pubertal
development, and serum reproductive hormone levels in 14 prepubertal and pubertal
KS boys, aged 10.0 to 13.9 years at the start of the study. Each boy had a testicular
biopsy, which was cryopreserved for possible future use in assisted reproductive
techniques in adulthood. A small part of each biopsy specimen was thoroughly
analyzed with histomorphometric and immunohistochemical methods. The impact of
genetic features of the supernumerary X chromosome on growth, pubertal
development, and testicular degeneration was also studied.
The KS boys had sufficient testosterone levels to allow normal onset and
progression of puberty. Their serum testosterone levels remained within the low-normal
range throughout puberty, but from midpuberty onwards, signs of a relative
testosterone deficiency emerged. Findings like a leveling-off in testosterone and
insulin-like factor 3 (INSL3) concentrations, high luteinizing hormone (LH) levels, and
exaggerated responses to gonadotropin-releasing hormone (GnRH) stimulation
suggest diminished testosterone secretion. But overall, no indisputable androgen
deficiency appeared in the KS boys, and thus they would require no androgen
supplementation before midpuberty.
A continuous increase occurred in serum INSL3 concentrations during pubertal
development in the healthy boys. Hence, INSL3 may serve as a novel marker for onset
and normal progression of puberty. Both in the healthy subjects and in the KS subjects,
secretion of INSL3 was dependent on LH, and during pubertal development there
existed a strong positive correlation with serum LH and testosterone levels as well as
with testicular volume. In KS subjects, measurements of serum INSL3 may be useful in
monitoring Leydig cell function.
In the KS boys the number of germ cells was already markedly lower at the
onset of puberty. The pubertal activation of the pituitary-testicular axis accelerated
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germ cell depletion. In KS, germ cell differentiation is—at least partly—blocked at the
spermatogonium or early primary spermatocyte stages, since no pachytene
spermatocytes were detected. In adolescent KS boys the presence of germ cells
correlated with serum reproductive hormone levels.
In the KS testes, immature Sertoli cells were incapable of transforming to the
adult type, and during puberty the degeneration of Sertoli cells increased markedly.
Both inhibin B subunits were expressed in the Sertoli cells of KS subjects that had
undetectable serum inhibin B concentrations, a phenomenon indicating an altered
inhibin B synthesis in KS. The older KS boys displayed an evident Leydig cell
hyperplasia, as well as fibrosis and hyalinization of the interstitium and peritubular
connective tissue. Altered immunoexpression of the androgen receptor (AR) suggests
that in KS boys during puberty a relative androgen deficiency develops at testicular
level.
Genetic features of the X chromosome appear to play a part in modulating KS
phenotypes. The present study suggested that parental origin of the supernumerary X
chromosome and the length of the CAG repeat of the AR gene influence pubertal
development and testicular degeneration, but do not influence growth before puberty or
body composition during puberty. Thus in KS, androgens may play a role in the
pathogenesis of the testicular degeneration.
The current study characterized by several means the testicular degeneration
process in the testes of adolescent KS boys and confirmed that this process
accelerates at the onset of puberty. Although serum reproductive hormone levels
indicated no hypogonadism during early puberty, the histological analyses showed an
already markedly reduced fertility potential in prepubertal KS boys. Genetic features of
the X chromosome affect the KS phenotype. Further studies are, however, needed to
reveal the mechanisms responsible for the testicular degeneration and the phenotypic
differences in KS.
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Klinefelter syndrome was first described by Harry F. Klinefelter in 1942 as a clinical
entity characterized by small firm testes, gynecomastia, hypogonadism, absent
spermatogenesis, and higher than normal concentrations of follicle-stimulating
hormone (FSH). This disorder was subsequently found to be caused by a
supernumerary X chromosome (Jacobs and Strong 1959). Today, we know that about
80% of cases are due to the numerical chromosome aberration 47,XXY; the remaining
20% have higher-grade chromosome aneuploidies (48,XXXY; 48,XXYY; 49,XXXXY),
46,XY/47,XXY mosaicism, or structurally abnormal X chromosomes (Lanfranco et al.
2004). The phenotype of KS males progressively deviates from normal as the number
of X chromosomes increases, whereas the KS subjects with mosaicism may have very
few clinical symptoms (Lanfranco et al. 2004).
Based on chromosome surveys in newborn children the estimated prevalence
of KS is about 1 in 600 newborn males, which makes KS the most common sex-
chromosome abnormality (Bojesen et al. 2003). It is among the most frequent genetic
causes of human infertility occurring in 11% of azoospermic men and in 4% of infertile
men (Van Assche et al. 1996). Although the classical phenotype of KS is widely
recognized, the disorder is severely underdiagnosed. A large Danish national registry
study shows that only approximately one-fourth of adult males with KS are diagnosed
(Bojesen et al. 2003). Less than one-tenth of the expected number are diagnosed
before puberty (Abramsky and Chapple 1997; Bojesen et al. 2003).
As described by Klinefelter, the histology of the testes in the adult KS male is
characterized by extensive fibrosis and hyalinization of the seminiferous tubules, and
hyperplasia of interstitium (Klinefelter et al. 1942), but the tubules may show residual
foci of spermatogenesis (Aksglaede et al. 2006). Introduction of testicular sperm
extraction (TESE) in combination with intracytoplasmic sperm injection (ICSI)
techniques has allowed nonmosaic KS males to father children (Schiff et al. 2005;
Tachdjian et al. 2003). Testicular biopsies of prepubertal boys have shown
preservation of seminiferous tubules with reduced number of germ cells, but Sertoli and
Leydig cells have (when described) appeared to be normal (Ferguson-Smith 1959;
Mikamo et al. 1968; Muller et al. 1995).
Until onset of puberty, 47,XXY boys have normal serum levels of testosterone,
FSH, LH, and inhibin B; thereafter, however, during puberty, FSH and LH levels
increase to hypergonadotropic levels, inhibin B decreases to undetectable levels, and
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testosterone after—an initial increase—levels off at a low or low-normal level
(Christiansen et al. 2003; Salbenblatt et al. 1985; Topper et al. 1982). Hence, most
adult KS males display a clear hypergonadotropism with a varying degree of androgen
deficiency; subsequently testosterone substitution therapy is widely used to avoid
symptoms and sequels of androgen deficiency (Lanfranco et al. 2004).
To date, the mechanisms and pathogenesis behind the testicular degeneration
process in KS are not known, and furthermore, the progression of this process has
been incompletely described. Neither has any study revealed the mechanisms
responsible for the wide variation in the 47,XXY phenotype, ranging from individuals
with severe hypogonadism or behavioral problems in childhood or both to those with
infertility as their sole presenting symptom as adults. This study was undertaken to
characterize the testicular degeneration process in KS that most probably accelerates
during puberty. The purpose was to find targets for therapeutic intervention with foci on
infertility and androgen deficiency that could offer these patients a better prognosis and
improvement in quality of life.
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REVIEW OF THE LITERATURE
CLINICAL FEATURES OF KS
The following section describes the clinical features of KS according to age. Many of
these findings may be attributed to the hypogonadism typical for this syndrome, but
some are instead caused directly by the chromosome aberration.
Neonatal period
KS is diagnosed prenatally by routine amniocentesis quite rarely, because the
association with advanced maternal age is weak (Lanfranco et al. 2004; Simpson et al.
2003). Birth weight, length, and head circumference of KS infants have been reported
as normal (Robinson et al. 1979; Ross et al. 2005) or low (Ratcliffe 1999; Stewart et al.
1979). Although most 47,XXY neonates appear normal at birth, the incidence of
cryptorchidism and inguinal hernia (Ratcliffe 1982), and of minor anomalies (fifth-finger
clinodactyly, high-arched palate) is increased (Ross et al. 2005; Visootsak et al. 2001).
Childhood and adolescence
During childhood, the KS boy often presents with language delay, learning disabilities,
or behavioral problems, and this often prompts child neurologists or child psychiatrists
to perform chromosome analysis, along with fragile X screening (Abramsky and
Chapple 1997; Visootsak et al. 2001). The mean intelligence of 47,XXY individuals is
only slightly below that of controls, but a wide range of IQs has been noted (Ratcliffe
1999; Robinson et al. 1986; Simpson et al. 2003; Sorensen 1992; Stewart et al. 1986).
In these studies, delayed speech development, difficulties in learning to read,
decreased mathematical ability, and poor short- and long-term memory were common
among the KS subjects. Furthermore, many had difficulties in relationships with peers
and siblings; they were quiet and unassertive with diminished self-esteem.
Neuromaturational delays include hypotonia, reduced gross and fine motor skills,
coordination, speed, and strength (Robinson et al. 1986; Ross et al. 2005; Visootsak et
al. 2001).
During childhood, a notable increase in height velocity occurs between 5 and 8
years of age, owing to greater leg growth, but the magnitude and timing of the pubertal
growth spurt does not differ from that of normal boys (Ratcliffe 1999; Robinson et al.
1986; Stewart et al. 1986). A tendency to central obesity is common (Ratcliffe 1999).
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Bone age demonstrates a pattern of slight early childhood delay, rising towards
average values at age 7 to 8 (Stewart et al. 1986). Several studies have shown that
onset of puberty is not delayed and that pubertal KS boys develop satisfactory
secondary sexual characteristics (Ratcliffe 1999; Salbenblatt et al. 1985; Topper et al.
1982). The reported incidence of gynecomastia varies from 56% to 88% but in most is
transient (Ratcliffe 1999; Salbenblatt et al. 1985; Visootsak et al. 2001).
Testicular volume of KS boys is already below normal during childhood (1.0-1.5
mL; normally 1.8 mL) (Laron and Hochman 1971; Ratcliffe 1982; Robinson et al. 1986).
During puberty, testicular volume initially increases to about 4 mL (range 2-10) at
midpuberty, but subsequently decreases to only 3 mL (range 2-7) during late puberty
(Ratcliffe 1999; Salbenblatt et al. 1985; Topper et al. 1982). Normally, the estimated
onset of release of spermatozoa (spermarche) occurs at a median age of 13.4 years, at
Tanner stage P2-3, and between testicular volumes of 4.7 and 19.5 mL (Nielsen et al.
1986; Tanner 1962). Healthy boys may have their spermarche as early as at Tanner
stage G2 (Hirsch et al. 1985).
Adulthood
In adulthood the KS subjects are detected among patients with azoospermia
presenting to infertility clinics (Abramsky and Chapple 1997). The adult KS male has a
testicular volume of 4.0 to 5.5 mL (normal men at least 15 mL), and the testes are
firmer than normal (Lanfranco et al. 2004; Smyth and Bremner 1998). Furthermore, the
typical adult phenotype includes higher than normal height, abnormally long legs, and a
feminine distribution of adipose tissue, including gynecomastia, decreased muscle
mass, and sparse or absent facial, axillary, pubic, or body hair (Aksglaede et al. 2007;
Lanfranco et al. 2004; Smyth and Bremner 1998). The KS patients often complain of
decreased libido and potency, and muscle strength (Lanfranco et al. 2004). Bojesen et
al. (2006) in a study based on hospital discharge diagnoses, report in KS subjects an
increased morbidity in all but one of the main diagnostic groups. The highest hazard
ratios were noted for congenital malformations, psychiatric disorders, and endocrine
and metabolic disorders. These results are in agreement with numerous earlier results
(Lanfranco et al. 2004; Simpson et al. 2003; Smyth and Bremner 1998). Concordantly,
KS males have significantly increased mortality overall (Bojesen et al. 2004; Swerdlow
et al. 2005a). They are at elevated risk for several cancers: lung cancer, breast cancer,
non-Hodgkin lymphoma, and mediastinal tumors (Bojesen et al. 2006; Swerdlow et al.
2005b). Extragonadal germ cell tumors are associated with KS (Aguirre et al. 2006;
Kaido et al. 2003).
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Investigations of the neuroanatomic bases of the cognitive phenotype in KS
have revealed a reduction in left temporal lobe gray matter, a finding consistent with
the verbal and language deficits associated with KS (Giedd et al. 2006; Giedd et al.
2007; Itti et al. 2003; Patwardhan et al. 2000; Shen et al. 2004). The atrophy seems
also to involve the limbic system, which agrees with findings of abnormalities of mood
and behavior in XXY males (Giedd et al. 2006; Shen et al. 2004). Patwardhan et al.
(2000) studied ten nonmosaic 47,XXY males diagnosed at birth, of which five had
received testosterone supplementation therapy for 2 to 10 years from the mean age
17.4. These five treated KS subjects showed relative preservation of gray matter in the
left temporal region and increased verbal fluency scores as compared with the five who
went untreated (Patwardhan et al. 2000).
TESTICULAR FUNCTION IN KS
The following section describes the age-specific data available on hormone levels
reflecting testicular function and activity of the pituitary-gonadal axis in KS.
Fetal period
When prenatal testosterone was investigated in amniotic fluid obtained at antenatal
diagnosis between 16 and 20 weeks of gestation from 20 47,XXY fetuses and from
46,XY and 46,XX controls of the same age, no significant difference was noted
between the two male groups; both had significantly higher testosterone levels than did
the 46,XX fetuses (Ratcliffe et al. 1994).
Neonatal period
At birth there already may exist some impairment of Leydig cell function. Cord-blood
testosterone was significantly lower in two 47,XXY infants and in one 46,XY/47,XXY
than in three control infants (Sorensen et al. 1981). However, another study comparing
testosterone levels of six KS infants to levels in a large cohort of normal infants showed
no significant difference (Ratcliffe 1982).
After birth, the pituitary-gonadal axis in healthy boys is strongly activated, which
is manifested by pubertal or even adult levels of serum FSH, LH, testosterone, and
inhibin B at the age of 3 months (Andersson et al. 1998a). After this minipuberty,
hormone levels decline to normal prepubertal levels until pubertal reactivation of the
pituitary-gonadal axis occurs. Lahlou et al. compared reproductive hormone levels
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during minipuberty in 18 prenatally diagnosed 47,XXY boys to those in 215 healthy
boys (Lahlou et al. 2004). The KS infants’ timing of peak serum testosterone was
similar to healthy infants’, but the levels in the KS boys were significantly lower from
birth to 8 months. In contrast, their serum LH, FSH, inhibin B, and anti-Müllerian
hormone (AMH) levels were normal. Another study found in 11 of 12 KS boys under
age 6 months lower than normal serum testosterone levels but normal gonadotropin
levels (Ross et al. 2005).
Childhood and adolescence
Prepubertal 47,XXY boys are characterized by normal serum levels of testosterone,
FSH, LH, and inhibin B until onset of puberty (Christiansen et al. 2003; Salbenblatt et
al. 1985; Stewart et al. 1986; Topper et al. 1982); their serum testosterone responses
to human chorionic gonadotropin (hCG) stimulation are normal (Salbenblatt et al. 1985;
Topper et al. 1982). During puberty, after an initial normal adolescent increase, serum
testosterone concentrations plateau and subsequently remain within the low-normal
range throughout puberty (Salbenblatt et al. 1985; Topper et al. 1982; Winter 1990).
These testosterone levels seem sufficient to allow in pubertal KS boys development of
satisfactory secondary sexual characteristics (Ratcliffe 1999; Salbenblatt et al. 1985;
Topper et al. 1982).
Serum estradiol (E2) levels in early pubertal 47,XXY boys are high, and the E2 /
testosterone ratios in particular remain high, irrespective of the presence or absence of
gynecomastia (Gabrilove et al. 1979; Salbenblatt et al. 1985; Stewart et al. 1986).
From midpuberty (at about age 13) onwards, KS subjects show a gradual
increase in FSH and LH concentrations to hypergonadotropic levels; FSH levels
increase somewhat earlier and more markedly than do LH levels (Ratcliffe et al. 1986;
Salbenblatt et al. 1985; Topper et al. 1982). At the same time, the responses of both
FSH and LH to gonadotropin-releasing hormone (GnRH) stimulation become
exaggerated (de Behar et al. 1975; Illig et al. 1975; Salbenblatt et al. 1985; Topper et
al. 1982). The increasing LH concentration reflects a compensatory mechanism to
maintain sufficient Leydig cell function. It has, however, been suggested that the
exaggerated FSH secretion in particular may accelerate the primary process of fibrosis
and hyalinization of the seminiferous tubules (Grumbach and Conte 1992; Salbenblatt
et al. 1985; Topper et al. 1982).
Serum levels of inhibin B are considered to reflect Sertoli cell function during
prepuberty and to become germ cell-dependent during midpuberty (Anawalt et al.
1996; Andersson et al. 1998b). Onset of normal male puberty is associated with
increasing serum concentration of inhibin B, and by pubertal stage 2 the adult serum
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level of serum inhibin B is already reached (Andersson et al. 1997; Raivio et al. 1998).
In patients with KS, inhibin B similarly shows a progressive increase before the clinical
onset of puberty, but this increase is followed by a decrease to low or unmeasurable
levels (Christiansen et al. 2003; Lahlou et al. 2004). In healthy subjects, serum
concentrations of AMH, another Sertoli cell marker, remain high throughout childhood
and wane during normal male puberty concomitantly with rising testosterone levels and
onset of meiosis in spermatogenesis (Al-Attar et al. 1997; Lee et al. 1996; Rey et al.
1993). This decrease in AMH levels most probably occurs also in KS subjects, since
Lahlou et al. (2004) found unmeasurable AMH levels in six KS adolescents aged 14 to
18, although longitudinal data from pubertal KS boys is lacking.
Adulthood
Gonadotropins and sex steroids. Adult KS patients are characterized by
hypergonadotropic hypogonadism. Their concentrations of LH and FSH are high; FSH
shows the best discrimination, with little overlap occurring with levels in normal
individuals (Lanfranco et al. 2004; Smyth and Bremner 1998). Serum inhibin B levels in
most adult KS subjects are undetectable (Anawalt et al. 1996; Christiansen et al. 2003;
Klingmuller and Haidl 1997).
In 65 to 85% of adult KS patients, serum testosterone concentrations are below
normal, but some show levels within the normal range (Aksglaede et al. 2007;
Lanfranco et al. 2004; Smyth and Bremner 1998). Serum concentrations of sex
hormone-binding globulin (SHBG) are high, causing a further decrease in biologically
active free testosterone (Lanfranco et al. 2004). Since serum testosterone has a potent
negative effect on leptin concentrations, the significantly higher serum leptin level in KS
men than in normal males indicates diminished androgen activity at tissue level (Ozata
et al. 1998; Wabitsch et al. 1997). On average, KS males have lower than normal E2
levels, but occasionally their serum E2 concentrations may be increased (Aksglaede et
al. 2007; Jockenhovel 2004; Lanfranco et al. 2004). KS males have higher E2 /
testosterone ratios than do normal males (Aksglaede et al. 2007).
Insulin-like factor 3. The peptide hormone INSL3, is a member of the relaxin-insulin
family, is secreted by prenatal and fully differentiated adult Leydig cells (Ivell and
Bathgate 2002), but is only weakly expressed in prepubertal Leydig cells and in Leydig
cells that have become hypertrophic or de-differentiated (Ivell and Bathgate 2002;
Klonisch et al. 1999). Measurements of INSL3 in normal men, in normal aging men,
and in men with various testicular pathologies have shown that INSL3 reflects the
functional status of the Leydig cells and that circulating INSL3 is entirely of testicular
origin (Anand-Ivell et al. 2006a; Bay et al. 2005; Foresta et al. 2004). Recently, findings
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reveal that adult KS patients have significantly lower than normal serum INSL3
concentrations (Bay et al. 2005; Foresta et al. 2004).
Production of both INSL3 and testosterone is related to LH (Bay et al. 2005;
Bay et al. 2006; Foresta et al. 2004), but recent data strongly suggest that the
production of these hormones is regulated differently; INSL3 secretion is probably
dependent on the long-term trophic effect of LH on Leydig cell differentiation (Bay et al.
2005; Bay et al. 2006). INSL3 is essential for the transabdominal part of testis descent
(Ivell and Bathgate 2002), but its biological significance in adults remains unclear.
Serum INSL3 levels in adult males are relatively high, 0.5 to 1.7 ng/mL (Bay et al.
2005; Foresta et al. 2004), and the gene encoding the INSL3 receptor LGR8 (leucine-
rich repeat-containing G-protein receptor 8) is expressed not only in the testis, but also
in several other tissues such as the pituitary, thyroid, and kidney (Hsu et al. 2002).
Kawamura et al. (2004) have suggested a paracrine role for INSL3 in germ cell survival
through suppression of apoptosis. These findings suggest that INSL3 may play an
important sex-linked endocrine role in the adult male.
TESTOSTERONE SUBSTITUTION THERAPY IN KS
When testosterone serum concentrations in patients with KS become low, lifelong
substitution therapy is indicated to prevent the symptoms and consequences of
androgen deficiency, and subsequently to improve quality of life. Testosterone
replacement results in increased masculinity, strength, libido, bone mineral density,
and body hair. It has a positive effect on mood and behavior, and reduces fatigue
(Lanfranco et al. 2004; Smyth and Bremner 1998). Beneficial effects of testosterone
therapy in hypogonadal men have been demonstrated (Jockenhovel 2004; Lanfranco
et al. 2004; Smyth and Bremner 1998), but it has, however, no positive effect on
testicular size and fertility.
It has been proposed that adolescent boys with KS may benefit from early
testosterone therapy; especially that androgen administration may have positive effects
on cognition and behavior (Myhre et al. 1970; Nielsen et al. 1988; Patwardhan et al.
2000; Simpson et al. 2003; Sorensen 1992; Visootsak et al. 2001). Reports that verify
hypoandrogenism in 47,XXY boys during puberty or examine their androgen status
before start of treatment are, however, lacking. And, to date, no placebo-controlled
studies showing the benefits of early testosterone substitution have been conducted.
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Consequently, the optimal age for initiating androgen therapy remains to be
determined.
TESTICULAR HISTOPATHOLOGY IN KS
At present, whether the degeneration of seminiferous tubules in KS is due to a primary
effect of the extra X chromosome on the development and function of germ, Sertoli,
and/or Leydig cells, or whether it is due to defect interactions between these cells is
unknown. Data are available on the age-specific changes in testicular histology in KS
subjects, but in actuality, the natural history of testicular degeneration in KS has been
incompletely characterized.
Fetal period
As studies of aborted fetuses at gestational ages 18 to 22 weeks have clearly shown,
the degenerative process may even start during fetal life (Coerdt et al. 1985; Murken et
al. 1974). In the testicular biopsies of midterm 47,XXY fetuses, whereas the density
and number of seminiferous tubules and mesenchymal structures appeared normal, a
reduced number of germ cells and an increased proportion of tubules devoid of germ
cells were visible (Coerdt et al. 1985). A testicular biopsy of a KS fetus aborted at 20
weeks of gestation with testes not yet descended showed pronounced hyperplasia of
Leydig cells (Murken et al. 1974). However, similar histological changes can be seen in
cryptorchid males with normal karyotypes (Hadziselimovic and Herzog 1990). In
47,XXY fetuses aborted at 17 and 20 weeks, two authors have reported normal
testicular histology (Flannery et al. 1984; Gustavson et al. 1978)
Neonatal period
Mikamo et al. (1968) showed, over the first year of life, a progressive diminution in the
number of spermatogonia. That quantitative study of testicular biopsies of three
47,XXY infants aged 3, 4, and 12 months revealed a drop in their number of
spermatogonia from 24 down to 0.1% of control value, but showed no effect on tubular
diameter. The number and appearance of immature Sertoli cells appeared normal, as
also did the interstitial tissue (Mikamo et al. 1968). A 13-day-old 47,XXY had germ cells
in only 23% of his seminiferous tubules, with a reduced number of spermatogonia
(Edlow et al. 1969). Numerous germ cells and immature Sertoli cells, plus normal
Leydig cells were evident in a testicular biopsy of a 4-week-old KS infant undergoing
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surgery for inguinal hernia, but a quantitative assay indicated a reduced number of
spermatogonia (Ratcliffe 1982). The one-month-old 47,XXY infant in the group of KS
boys studied by Muller et al. (1995) showed a normal number of germ cells in the
biopsies despite bilateral undescended testes.
Childhood and adolescence
The first report of a testicular biopsy in a chromatin-positive 10-year-old with KS
showed normal histology (Bunge and Bradbury 1957). Based on this fact and on
biopsies of two 11- and 13-year-old KS boys, Siebenmann and Prader made the
interpretation that testes in KS subjects are normal until puberty, when development of
the characteristic tubular hyalinization is preceded by depletion of germ cells
(Siebenmann and Prader 1958). Ferguson-Smith, reporting in 1959 on eight retarded
prepubertal chromatin-positive KS boys aged 7 to 12, noted the reduced size of their
seminiferous tubules and a reduction in or complete absence of spermatogonia. A
minority of the tubules were normal, containing a normal amount of spermatogonia; the
majority were smaller tubules with undifferentiated Sertoli cells. The oldest patient,
aged 12 and still prepubertal, showed maturation of Sertoli and Leydig cells but an
almost complete absence of germ cells, and in addition, in some areas early tubular
hyalinization. This boy also showed elevated urinary FSH secretion (Ferguson-Smith
1959).
Muller et al. (1995), studying testicular biopsies of 11 KS boys between the
neonatal period and age 13, found no germ cells in their nine KS boys older than 2
years. The number of germ cells was normal only in a one-month-old 47,XXY infant
and in a 4-year-old mosaic 46,XY/47,XXY boy. It should, however, be noted that in that
study all were cryptorchid, a condition which also has a detrimental effect on the
seminiferous epithelium (Hadziselimovic and Herzog 1990). In contrast, a 15-year-old
KS boy with no history of cryptorchidism had sperm-containing tissue successfully
extracted and cryopreserved, (Damani et al. 2001). Muller et al. (1995) did not perform
qualitative or quantitative studies of Sertoli cells; Leydig cells found in a one-month-old
and in a 13-year-old patient were judged as normal. Furthermore, mean tubular
diameter was reduced in eight subjects, the exceptions being the three boys aged one
month and 11 and 13 years; the two older boys showed signs of onset of puberty
(Tanner stage P2) (Muller et al. 1995).
These hormonal and clinical data, and in addition, sparse histological
observations, all indicate the possibility that when healthy boys are experiencing
spermarche, KS boys’ testicular function is at least in some respects relatively normal.
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Adult life
As described by Klinefelter in 1942, testicular histology in the adult patient is
characterized by extensive fibrosis and hyalinization of the seminiferous tubules and
hyperplasia of the interstitium. The patchy nature of testicular histology, with its more-
and its less-affected areas, has been described (Foresta et al. 1999; Gordon et al.
1972; Heller and Nelson 1945; Nistal et al. 1982; Skakkebaek et al. 1969a;
Skakkebaek 1969b; Steinberger et al. 1965). Foresta et al. (1999) for example, studied
ten 47,XXY males aged 28 to 37 years and found the Sertoli-cell-only (SCO) pattern in
eight of the ten biopsies, whereas two showed Sertoli cells and a few spermatogenic
cells. Skakkebaek (1969b) when studying Sertoli-cell morphology, described two types
of tubules: those containing either small immature Sertoli cells (chromatin positive) or
containing larger and more differentiated Sertoli cells (chromatin negative). Later,
studies of the cytologic features of such immature Sertoli cells have suggested a lower
activity than that of mature Sertoli cells, probably resulting in compromised protein
synthesis (Nistal et al. 1982). Furthermore, measurement of the amount of androgen-
binding protein (ABP) secreted in fragments of seminiferous tubules in vitro has shown
that KS men without testicular spermatozoa, when compared with KS men positive for
spermatozoa, have a greater degree of Sertoli cell dysfunction (Yamamoto et al. 2002).
Regadera et al. showed in their immunohistochemical and quantitative study that 78.9
± 9.1% of the Leydig cells were normal in the adult KS males compared to 96.0 ±
10.0% in controls, and in KS that the functional activity of the Leydig cells was reduced
(Regadera et al. 1991).
Animal models
The development of XXY mouse models provides a tool to investigate maturation and
degeneration of the KS testis (Bronson et al. 1995; Hunt and Eicher 1991; Lue et al.
2001). In the XXY testis during the period of germ cell proliferation in the early stages
of testis differentiation, Hunt et al. (1998) noted significantly reduced germ cell
numbers. They hypothesized that germ cell demise reflects a defect in somatic/germ
cell communication, since in an in vitro system, the proliferative potential of fetal germ
cells from XXY mice was indistinguishable from that of normal males. Furthermore,
they noted a progressive decline in the number of germ cells during the early postnatal
period until 12 days postpartum, when hardly any remaining germ cells were
recognizable (Hunt et al. 1998). In the same manner, Lue et al. (2001) found that germ
cells began to degenerate in the XXY mice at 7 days of age with a progressive loss
resulting in a total absence of germ cells in the adult animals. Hence, germ cell loss in
20
XXY mice begins at a time when germ cells in normal mice reinitiate mitosis and before
the onset of germ cell meiosis; hypertrophy and hyperplasia of Leydig cells and
changes in Sertoli cells indicating cellular inactivity were also evident (Lue et al. 2001).
FERTILITY IN KS
KS subjects are traditionally described as infertile, with only exceptional cases of
spontaneous paternity reported (Laron et al. 1982; Terzoli et al. 1992) Semen analysis
most often reveals azoospermia; in one cohort of KS males, only 8.4% had
spermatozoa in their ejaculate (Lanfranco et al. 2004). Some spermatogonia in KS
subjects are capable of completing the spermatogenic process leading to the formation
of mature spermatozoa, but do so at an increased risk for genetic imbalance (Staessen
et al. 2003). Two hypotheses have been proposed to explain this phenomenon: First,
that 47,XXY spermatogonia undergo meiosis to produce hyperploid spermatozoa
(Bielanska et al. 2000; Chevret et al. 1996; Ferlin et al. 2005; Foresta et al. 1999;
Yamamoto et al. 2002); second, that rare patches of normal XY germ cells occurs, but
as a result of a compromised testicular environment, these cells are susceptible to
meiotic abnormalities (Bergere et al. 2002; Blanco et al. 2001; Mroz et al. 1998).
Natural conception thus rarely occurs for Klinefelter couples, and most often the
only hope for biological paternity is testicular sperm extraction (TESE) combined with
intracytoplasmatic sperm injection (ICSI). The initial success rate of TESE in adult
47,XXY males in small series has been reported at 40 to 50% (Lanfranco et al. 2004);
later, a rate has been achieved as high as 70% (Schiff et al. 2005). Once sperm have
been obtained, live birth rates have been reported of 20 to 46% (Schiff et al. 2005;
Staessen et al. 2003). The fact that spermatogenesis seems to decline with age makes
it tempting to retrieve germ cells at an earlier age for cryopreservation and future
utilization (Damani et al. 2001; Emre Bakircioglu et al. 2006; Ichioka et al. 2006; Lin et
al. 2004; Okada et al. 2005). However, Schiff et al. (2005) could in their study not
verify this age effect; they were able to perform several TESE procedures successfully
for the majority of their patients.
In the KS male, the only predictive factor for successful sperm recovery seems
to be testicular histopathology (Westlander et al. 2001), but even with no sperm found
in a biopsy, TESE has been successful (Schiff et al. 2005; Vernaeve et al. 2004).
Neither testicular ultrasonography, extensive chromosome analyses, degree of
virilization, testicular volume, nor serum testosterone, FSH, LH, nor inhibin B levels are
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predictive for outcome of TESE (Vernaeve et al. 2004; Westlander et al. 2001). In fact,
even patients with inhibin B below the detection limit have undergone successful TESE
(Westlander et al. 2003). To date, the births of more than 50 healthy children of KS
fathers have been reported following the use of ICSI (Ferlin et al. 2005). In a triplet
gestation, one 47,XXY fetus was reduced (Ron-El et al. 2000). Because of the risk of
producing offspring with sex-chromosome abnormalities most investigators recommend
professional genetic counseling and standard prenatal diagnosis techniques
(Denschlag et al. 2004; Ferlin et al. 2005; Hennebicq et al. 2001; Staessen et al. 2003).
GENETICS
For autosomal trisomies, maternal errors predominate, accounting for nearly 95% of
cases. In contrast, the origin of 47,XXY is more complicated. Paternal meiosis I errors
(leading to 47,XmXpY) are common, accounting for 40 to 60% of cases (Iitsuka et al.
2001; Lanfranco et al. 2004; Simpson et al. 2003; Thomas and Hassold 2003). In the
maternally derived cases (47,XmXmY), the extra X chromosome is due either to non-
disjunction during the first (MI) or second (MII) meiotic division, or in a post-zygotic
mitotic division (Iitsuka et al. 2001; Lanfranco et al. 2004; Simpson et al. 2003; Thomas
and Hassold 2003). No obvious increased risk for conception of an affected child
occurs with advanced paternal age (Lanfranco et al. 2004; Simpson et al. 2003), but
among maternally derived cases, an association with increasing maternal age exists,
but this effect is limited to the subset of cases originating at MI (Thomas et al. 2001).
Several genetic features of the X chromosome have been proposed to affect
the KS phenotype, but to date this issue has not been thoroughly investigated. The
parental origin of the supernumerary X chromosome results in different doses of
paternally and maternally derived genes. Furthermore, due to imprinting, the paternal
and maternal alleles may be differentially expressed (Iitsuka et al. 2001). As a dosage-
compensation mechanism in subjects with two X chromosomes, one of the X
chromosomes is randomly inactivated (Iitsuka et al. 2001; Willard 2001). What has,
however, been shown is that over 15% of X chromosomal genes escape inactivation
(Carrel and Willard 2005), and consequently, a widely accepted hypothesis is that
these genes are responsible for many of the features of KS (Simpson et al. 2003). As
in normal females, skewed X chromosome inactivation, defined as > 80% preferential
inactivation of one of the X chromosomes, can also occur in KS (Iitsuka et al. 2001;
Willard 2001). This leads to predominant expression of the genes on one of the X
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chromosomes, and in 47,XmXpY subjects, skewed inactivation of the Xm could result in
a situation where only paternally derived genes are expressed. In the case of Xp
inactivation, the situation equals that of a normal male and this causes perhaps a less
severe phenotype.
In cases of errors in MII or in mitosis, the 47,XXY subject has two identical X
chromosomes (Lanfranco et al. 2004). This isodisomy can, as in cases of skewed X
inactivation, lead to expression of recessive mutations of X-linked genes and,
accordingly, to a more severe phenotype.
Androgen-related genes may play a particular role in modulating differences in
KS phenotype. The androgen receptor (AR) gene is located on the X chromosome.
The N-terminal domain of exon 1 of the AR gene contains a highly polymorphic CAG
repeat, the length of which is inversely associated with receptor activity (Zitzmann and
Nieschlag 2003). It is possible that a subtle modulation of AR function contributes to
the variability in KS phenotypes, especially since most of these patients have low-
normal or low androgen levels.
In the degeneration process of the testes in KS, inhibin B may be of special
interest, since p120, a candidate for an inhibin B-binding protein, is encoded by the
Xq25 (Chong et al. 2000). Furthermore, among genes on the X chromosome, a large
number belong to the cancer-testis antigen family and are expressed in testicular germ
cells (Scanlan et al. 2002; Wang et al. 2001). Mroz et al. showed that X-reactivation
occurs during germ cell development in the XXY mouse, and it is assumed that for the
survival of germ cells in the mature testis the proper X-chromosome dose is crucial
(Mroz et al. 1999). Hence, molecular mechanisms induced by an altered dose of X-
encoded genes in testicular cells may, during puberty, initiate the degeneration process
in the testes of boys with KS.
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AIMS OF THE STUDY
The aims of this study were:
1. to determine whether adolescent KS boys start displaying signs of Leydig
cell dysfunction during puberty by assessment of clinical and biochemical
characteristics during a longitudinal observation period.
2. to characterize the testicular degeneration process in adolescent KS boys
by histomorphometry and immunohistochemistry.
3. to investigate the impact of genetic features of the X chromosome on
growth during childhood and adolescence, on onset and progression of




The parents of each boy gave their informed consent for their son’s and their own
participation in this study approved by the ethics committee for pediatrics, adolescent
medicine and psychiatry of the Hospital District of Helsinki and Uusimaa.
SUBJECTS AND STUDY PROTOCOL
From the pediatric endocrinology outpatient clinic at the Helsinki University Central
Hospital, Hospital for Children and Adolescents, 14 subjects with the nonmosaic
karyotype 47,XXY were enrolled. One boy, patient 14KS, was diagnosed by
amniocentesis, and the other 13 boys were diagnosed between 5 and 10.5 years of
age by child neurologists. Karyotype analyses were performed for nonendocrinological
indications (problems with speech, learning, behavior). None of these patients had a
history of previous cryptorchidism, nor were any on androgen therapy. Before the start
of systematic prospective surveillance, these patients had been followed up irregularly
at visit intervals of 6 to 24 months in the same clinic, and after this study, the routine
clinical visits continued at an interval of 6 months. These visits included routine
reproductive hormone analyses, physical examination with measurement of testicular
size, and assessment of Tanner pubertal stage. Data from these clinical surveillance
visits were collected from patient records and merged with data obtained during the
prospective part of the study.
At the start of the systematic follow-up, the median age of the subjects was 11.5
years (range 10.0-13.9). They were followed prospectively for 4 to 25 months (median,
18). During the systematic surveillance, they visited the Hospital for Children and
Adolescents every fourth month. At each visit, a physical examination including
measurements of height, weight, and testicular volume, and staging of puberty was
performed. Once a year, skeletal age was assessed and a GnRH stimulation test
performed. Sera for hormone measurements were collected every fourth month or at
least once a year. For genetic studies (III), blood samples were collected from all 14
boys and 27 parents. Reported heights of all parents were recorded.
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From each KS subject (mean age 11.9; range 10.1-14.0 years) an open
testicular biopsy specimen was taken under general anesthesia; three of the boys
(patients 8KS-10KS) had a second biopsy specimen taken from the contralateral testis
1.0 to 1.6 years after the first one. The major portion of each of these 17 biopsy
specimens was cryopreserved for possible further use in assisted reproduction in
adulthood.
For comparison of serum testosterone and E2 levels in KS boys to values in
healthy adolescent boys, recently published reference values came from 55 healthy
Swedish boys (Ankarberg-Lindgren and Norjavaara 2004; Ankarberg-Lindgren 2005)
(II). These boys, aged 5.0 to 18.6 years, had undergone serial sampling for 24-h serum
testosterone and E2 profiles once or repeatedly during pubertal development; their
venous blood samples were drawn six times during 24 h.
For comparison of longitudinal changes in serum concentrations of SHBG,
PSA, leptin, FSH, LH, and inhibin B levels (II), values were used from 25 healthy,
untreated Finnish boys with constitutional delay of puberty (CDP) previously followed
up in the same unit of the Hospital for Children and Adolescents (Raivio et al. 2004;
Wickman et al. 2001). For assessment of laboratory values for the CDP group when
compared to the KS group, BA was used rather than chronological ages (CA), since BA
in the CDP group was delayed. For assessment of laboratory values in KS boys CA
was used (II), because differences between BA and CA in these boys during the study
period were small.
In KS boys, to compare longitudinal changes during puberty in serum INSL3
levels and in simultaneously measured testosterone and LH levels (IV), values came
from 30 healthy boys aged 9.0 to 14.5 years; they were previously enrolled in a study
on idiopathic short stature (ISS) at the outpatient clinic for pediatric endocrinology of
the Hospital for Children and Adolescents. The selection of patients and study protocol
have been described in detail (Hero et al. 2005).
In order to study the effect of aromatase inhibitors on delaying bone maturation
to increase predicted adult height, these ISS boys were randomized to receive either
the aromatase inhibitor letrozole (Lz; Femar®, Novartis AG, Basel, Switzerland) at a
dose of 2.5 mg or placebo (Pl) orally once daily for 2 years. During treatment, these
boys were examined every 6 months, and again 12 months after cessation of
treatment. Their follow-up included the same investigations as the follow-up of the KS
boys. BA rather than CA was used in the comparisons between the KS and ISS groups
(IV), since the majority of the ISS boys had delayed BA.
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CLINICAL ASSESSMENT
Puberty was staged according to Tanner (Tanner 1962). The length and width of the
testes were measured with a ruler to the nearest millimeter. Testicular volumes were
calculated by the formula 0.52 x width2 x length, converted to milliliters (Hansen and
With 1952) and expressed as the mean volume of the left and the right testis. Bone
ages were determined by the method of Greulich and Pyle (Greulich and Pyle 1959).
Body mass index (BMI) was calculated as weight (kg) divided by height squared
(m2) (II, III). Midparental height (SD) for each KS boy was calculated by subtracting 171
from the arithmetic mean of the parents’ heights and dividing this difference by 10 (III).
Predicting adult height for the KS subjects was by the method of Bayley and Pinneau
(Bayley and Pinneau 1952) (III). Height in centimeters was converted to SD scores by
means of age-specific growth norms for normal Finnish boys (Sorva et al. 1984) (III).
LABORATORY ASSAYS
The blood samples were drawn between 0830 h and 1530 h. After clotting, the serum
was separated by centrifugation and stored at –20 C or –70 C until analysis.
GnRH stimulation test. GnRH (Relefact®, 3.5 μg/kg, maximum 100 μg; Hoechst
Marion Roussel, Deutschland GmbH, Frankfurt, Germany) was administered
intravenously. LH concentrations were measured from samples obtained at 0 (before),
20, 30, and 60 minutes, and FSH concentrations at 0, 30, 60, and 90 minutes after
administration of GnRH. The GnRH-induced gonadotropin response was defined as
the difference between the basal and the GnRH-induced peak gonadotropin
concentrations.
Gonadotropins. Serum FSH and LH levels were measured by ultrasensitive
immunofluorometric assays, as described (Dunkel et al. 1990). The sensitivity of the
assays was 0.05 IU/L, but FSH and LH concentrations < 0.1 IU/L were treated as 0.1
IU/L. For FSH, interassay CV was < 3.3% and intraassay CV < 4.4%; for LH these
were < 4.4% and < 4.1%.
Testosterone. Serum testosterone levels were measured by two different
radioimmunoassays (RIA). The first assay was applied to measure testosterone
concentrations (I, III, V) after separation of steroid fractions on a Lipidex-5000
microcolumn (Packard-Becker, B. V. Chemical Operations, Groningen, The
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Netherlands) (Apter et al. 1976). The detection limit for testosterone was 0.1 nmol/L.
The interassay CV was < 15% and the intraassay CV was < 9%. The second method
(II, IV) was an ultrasensitive (sensitivity 0.03 nmol/L) modified RIA (Spectria
testosterone, Orion Diagnostica, Espoo, Finland) (Ankarberg and Norjavaara 1999).
The intraassay CV was 11% at 0.2 nmol/L, and < 7% at concentrations > 0.9nmol/L;
the corresponding interassay CV was 15% and < 10%, respectively.
17b-estradiol. Serum E2 concentrations were measured with a modified RIA (Spectria
estradiol, Orion Diagnostica) after diethyl ether extraction (Ankarberg-Lindgren 2005;
Norjavaara et al. 1996). The assay detection limit was 4.5 pmol/L, the intraassay CV
was 13% at 19 pmol/L, and interassay CV 12% at 22 pmol/L.
Sex hormone-binding globulin. Serum SHBG concentrations were measured by
time-resolved fluoroimmunoassay (TR-FIA, Perkin-Elmer Life Sciences, Turku, Finland)
with inter- and intraassay CVs both < 5% according to the manufacturer.
Leptin. Serum leptin was quantified with a commercially available RIA from Linco
Research Inc., St. Charles, MO, USA. The detection limit of this assay is 0.5 μg/L.
Interassay CV was < 7% (concentration range 5-25 μg/L).
Prostate-specific antigen. Serum PSA was quantified with a time-resolved
immunofluorometric assay (Prostatus PSA EQM DELFIA, Wallac, Turku, Finland). The
detection limit for PSA was 0.02 μg/L. Interassay CV was < 4% at PSA concentrations
0.2 to 100 μg/L.
Inhibin B. Serum inhibin B levels were measured by a commercially available immuno-
enzymometric assay according to manufacturer’s instructions (Serotec, Oxford, UK).
The detection limit was 15.6 pg/mL. The interassay CV was < 15% and the intraassay
CV < 5%.
Anti-Müllerian hormone. Serum AMH levels were measured by a commercially
available immunoenzymometric assay according to manufacturer’s instructions
(Immunotech-Coulter, Marseille, France). The detection limit for AMH was 5.5. pmol/L,
and the interassay CV was 13.4%.
Insulin-like factor 3. INSL3 serum concentrations were analyzed in a semicompetitive
time-resolved fluorescence immunoassay (TR-FIA), based on purified synthetic
hINSL3, an hINSL3-specific rat antiserum, an hINSL3 tracer labeled with chelated Eu3+
ions, and a secondary goat anti-rat g-globulin antibody immobilized on the surface of
microtiter wells (Bay et al. 2005). This assay has a detection limit of 0.05 ng/mL and
intra- and interassays CVs of 8.0 and 11.3%.
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ANALYSES OF THE TESTICULAR BIOPSIES
The major portion of each of the testicular biopsies of the 14 KS boys was
cryopreserved for possible further use in assisted reproduction in adulthood.
Histomorphometric analyses of the testicular biopsies (I). For histomorphometric
analyses, a piece of each testicular biopsy specimen was fixed in glutaraldehyde, then
further subdivided and embedded in Epon, sectioned at 1.0 μm, and stained with
toluidine blue. Histomorphometric analysis was performed by light microscopy at a total
magnification of x 400.
The Leydig cells were morphologically classed as fetal, juvenile, or adult types
by the following criteria: Leydig cells were regarded as fetal if they had an extrinsically
located large nucleus with two or more nucleoli, as juvenile if they had an irregular
nucleus and dark cytoplasm, and as adult if they were large cells with a round nucleus
and cytoplasm containing crystalloid and lipid droplets.
The Sertoli cells were morphologically classed as Sa, Sb, and Sc types and
were regarded as of Sa type if they were round with scant cytoplasm and had a round
nucleus, and as Sb if they were oval and larger, with an irregular oval nucleus and
cytoplasm with recognizable structures. They were classified as Sc or adult if they were
large and had a nucleus displaying one or more deep invaginations (Hadziselimovic
and Herzog 1990; Nistal et al. 1982; Seguchi and Hadziselimovic 1974).
For all specimens containing germ cells, germ cell counts (number of adult pale
type spermatogonia per seminiferous tubule, Ap / tubule, and number of adult dark type
spermatogonia, Ad / tubule) were calculated per cross-section of tubule.
Spermatogonia were regarded as type A if they were of an irregular shape with a round
nucleus. Furthermore, they were regarded as Ap type if the nucleus had one or two
nucleoli and as Ad if the nucleus had one or two pale round areas (Hadziselimovic and
Herzog 1990). All tubules from an average of nine sections (range, 6-12) per biopsy
specimen were studied. The average number of tubules studied per biopsy specimen
was 130 (range, 71-177). Germ cell numbers were quantitatively compared to those of
available normal testicular biopsies. Eleven identically prepared testicular specimens
from adolescent boys were analyzed (11 yr, n = 5; 13 yr, n = 4; 15 yr, n = 1; and 19 yr,
n = 1). Indications for these biopsies had been scrotal pain (n = 5), hydatid torsion (n =
3), retractile testis (n = 1), and paratesticular fibrosis (n = 1); one specimen was taken
postmortem (accidental death).
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For electron microscopy, two Epon-embedded specimens were sectioned at 50
nm with a Reichert E ultra microtome (Reichert Jung, Vienna, Austria) and stained with
uranyl acetate and lead citrate. Observations were made with a JEOLJEM 1200 EX
transmission electron microscope (JEOL, Tokyo, Japan).
Immunohistochemical analyses of the testicular biopsies (V). A small piece of
each testicular biopsy specimen was fixed in formalin and embedded in paraffin.
Thirteen identically prepared testicular specimens from the tissue archive of Helsinki
University Central Hospital served as controls for the immunohistochemical
experiments. These biopsies had been performed as part of a routine clinical screening
for lymphoblastic infiltration in boys (mean age 11.0; range 7.5-16.5 yr) previously
treated for acute lymphoblastic leukemia/lymphoma. These specimens were judged by
morphological inspection to be normal. As adult controls, biopsy specimens were
obtained during treatment from the histologically normal contralateral testes of 18- to
39-year-old men diagnosed with testicular carcinoma in situ (CIS) or with a testicular
germ cell tumor (affected tissues served as positive controls) at the University Hospital
(Rigshospitalet) in Copenhagen, Denmark.
The protein expression profile / pattern was analyzed by IHC with several
antibodies; see Table 1 for details. The staining was performed on 4-μm thick sections
by a standard indirect peroxidase method as reported for several of the antibodies
(Andersson et al. 1998b; Aubry et al. 2001; Bartkova et al. 2001; Hoei-Hansen et al.
2004; Rajpert-De Meyts et al. 1999; Rajpert-De Meyts et al. 2004; Satie et al. 2002;
Visfeldt et al. 1999). Briefly, most of the dewaxed and rehydrated sections were pre-
treated in a microwave oven in a buffer. Subsequently, the sections were incubated
with 1.5% H2O2 to inhibit the endogenous peroxidase, followed by diluted non-immune
goat serum to block unspecific binding sites. Incubation with the diluted primary
antibody was overnight at 4°C. For the negative control, at least one section was
incubated with a dilution buffer for each investigation. Subsequently, a secondary
biotinylated goat anti-mouse link antibody was applied, followed by a horseradish
peroxidase-streptavidin complex. Between all steps, the sections were thoroughly
washed. The bound antibody was visualized with an aminoethyl carbazole substrate
(all reagents from Zymed, San Francisco, CA, USA). Sections were lightly
counterstained with Mayer’s hematoxylin.
Two observers (A.W. and C.H-H) systematically scored the stainings. If any
discrepancy arose, slides were re-evaluated by a third observer (E.R-D) to lead to a
consensus. Staining intensity of the cells or tubules was assessed, with scores being
++, strong staining; +, intermediate staining; ±, weak staining; 0, no specific staining
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Table 1. Characteristics of antibodies applied in the immunohistochemical analyses of the testicular biopsies.
Antibody Inclusion criteria Pretreatment Dilution Details
AP-2gamma Gonocyte marker Urea buffer 1:30 SC-12762;
Santa Cruz Biotechnology Inc., CA, USA
Androgen receptor X-linked androgen-related TEG buffer 1:40 MS-443-P;
(AR) Sertoli and Leydig cell marker NeoMakers, Fremont, CA, USA
Anti-Müllerian hormone Androgen-related immature Urea buffer 1:150 Gift from Richard L. Cate, x
(AMH) Sertoli cell marker NeoMakers, Fremont, CA, USA
CHK2 Spermatogonia marker Citrate buffer 1:5000 Gift from J. Bartek, 
Danish Cancer Society, Copenhagen, DK
inhibin alpha-subunit Sertoli and Leydig cell marker Citrate buffer 1:10 R1alpha,
see Andersson et. al. (1998a)
inhibin betaB-subunit Sertoli and Leydig cell marker Citrate buffer 1:6 MCA-1661;
Serotec, Raleigh, NC, USA
MAGE-A4 X-linked spermatogonia marker Citrate buffer 1:200 Gift from Giulio Spagnoli, 
Ludvig Inst. for Cancer Research, Lausanne, CH
MIC-2 X-linked Sertoli cell marker TEG buffer 1:50 CD99, M3601; 
DakoCytomation, Glostrup, DK
NY-ESO-1 X-linked spermatogonia marker None 1:50 Gift from Giulio Spagnoli, 
Ludvig Inst. for Cancer Research, Lausanne, CH
OCT-3/4 Gonocyte marker Urea buffer 1:250 SC-5279;
Santa Cruz Biotechnology Inc., CA, USA
Monoclonal antibodies, mouse
TEG buffer = TRIS 6.06g/5L, EGTA 0.95g/5L, pH= 9.0; Urea buffer = 5% carbamide, pH = 8.5; Citrate buffer = 10 mmol/L, pH = 6.0.
detected. The proportion of stained cells or tubules in each section was semi-
quantitatively evaluated as a percentage of positive cells/tubules.
GENETIC STUDIES
Genomic DNA was extracted from whole EDTA blood with the PUREGENE® DNA
isolation kit (Gentra Systems, Minneapolis, MN, USA). Parental origin of the X
chromosomes were determined by genotyping each boy and both parents (with the
exception of one father) at 10 microsatellite loci: DXS6807, DXS989, DXS1068,
DXS1003, DXS6800, DXS6797, DXS1001, DXS984, DXS1193 and DXS1073. The
length of the CAGn repeat in exon 1 of the AR gene and the degree of X-chromosome
inactivation were determined essentially as outlined in Suzuki et al. (Suzuki et al.
2001). The CAG alleles were sized initially by genotyping, and the lengths of the
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repeats subsequently confirmed by sequencing all homozygous samples. The degree
of skewing of X inactivation was estimated for all heterozygous samples according to
equations outlined in Iitsuka et al. (2001), using the peak area values for each allele. All
genotyping and sequence reactions were electrophoresed in an ABI 3700 (Applied
Biosystems, Foster City, CA, USA) and analyzed with GeneMapper v3.7 (Applied
Biosystems) and Sequencer v4.5 (Gene Codes Corporation, Ann Arbor, MI, USA),
respectively.
X-weighted biallelic mean CAG repeat length was calculated by a method
previously described (Hickey et al. 2002): Each allele in a genetic pair was multiplied
by its percentage of expression (100% minus % inactivity) and summed.
STATISTICS
Descriptive data are reported as medians and ranges or as means ± SD. In those
cases with no laboratory analyses at the time of testicular biopsy, values were
interpolated from data obtained before and after the biopsy with the assumption that
changes between the two time-points had been linear (I, V). To reduce frequency bias,
means were calculated to obtain for each subject one value for each age or puberty
stage (II, IV). Furthermore, because the same subjects were investigated repeatedly
during follow-up, the method of summary measures was also used (Matthews et al.
1990) (II). Arithmetic means were first calculated for each individual; these individual
means served as raw data in further tests. Spearman’s rank correlations were
calculated for associations between inhibin B and testosterone (I), AMH and
testosterone (I), and between continuous parameters and X-weighted biallelic mean
CAG repeat length (III). Differences between the Lz- and Pl-treated groups of ISS boys
were analyzed by repeated measures ANOVA (IV). Relations between INSL3 and
other hormones were tested by linear regression analysis (IV). For comparisons
between groups, the unpaired two-tailed Student´s t test (I, II, IV) was used, and the
non-parametric Mann-Whitney U-test (III, V) in the absence of normal distribution. A




Clinical progression of puberty (II)
Figure 1 shows clinical progression of puberty in the 14 boys with KS. Both onset and
progression of puberty, as assessed by Tanner stages, fell within the normal range for
healthy Finnish boys (Ojajärvi 1982) (Figs. 1A and B, Table 2). At the end of the study
period, only one (subject 1KS), aged 12.5 years, was at P1, but had entered puberty
(stage G2). Although Tanner stages progressed normally during follow-up, there
occurred an arrest in testicular growth, and testicular volumes of the 14 KS subjects
never exceeded 4.5 mL (Fig. 1C and Table 2). Mean testicular volume 2.0 mL,
accepted as indicating clinical onset of puberty, occurred at a median age of 12.6 years
(range, 11.7-13.9, n = 13), and 3.0 mL at 13.1 years (11.8-14.9, n=8) (Fig. 1C and
Table 2).
During follow-up, gynecomastia occurred in 11 KS boys; at G2 in two boys: at
G3 in five, and at G4 in four. In five of these boys, it was reversible; when
gynecomastia occurred, only one of these 11 boys had reached Tanner stage M3.
Figure 1.
Pubertal development in 14 boys
with KS. A and B: puberty staged
according to Tanner. Gray areas
= mean age ± 2 SD for healthy
Finnish boys (Ojajärvi 1982). C :
longitudinal changes in mean
testicular volumes. Gray area =
range of the volume of the right
testis in healthy pubertal Swiss
boys (Largo and Prader 1983). D:
progression of bone age (BA)
against chronological age. Gray
area = mean BA ± 2SD for
healthy Finnish boys (Ojajärvi
1982).
33
Table 2. Follow-up of 14 adolescent boys with KS. Means ± SD  (number of patients) and *median, range (n) are displayed
Age (years) 10-11 11-12 12-13 13-14 14-15 15-16
Tanner P-stage* 1 (9) 1, 1-2 (9) 2, 1-3 (13) 2.5, 1-4 (11) 3, 1-4 (9) 4, 3-5 (4)
Tanner G-stage* 1 (9) 1, 1-2 (9) 2, 1-4 (13) 3.5, 2-4 (11) 4, 2-5 (9) 4, 3-5 (4)
Mean testicular volume (mL) 1.1 ± 0.5 (5) 1.8 ± 0.9 (9) 2.1 ± 0.5 (12) 2.9 ± 0.5 (11) 2.6 ± 0.7 (9) 2.4 ± 1.2 (4)
Bone age (years) 9.5 ± 2.1 (4) 11.0 ± 1.2 (7) 12.3 ± 1.1 (9) 13.1 ± 1.0  (11) 13.8 ± 0.8 (7) 15.0 ± 0.7 (2)
BMI (kg/m2) 17.7 ± 2.2 (8) 19.3 ± 2.7 (10) 19.3 ± 2.9 (13) 19.7 ± 2.4 (11) 19.7 ± 3.1 (9) 18.9 ± 2.0 (4)
Testosterone (nmol/L) 0.53 ± 0.43 (4) 0.78 ± 0.37 (9) 2.81 ± 2.68 (7) 5.65 ± 4.50 (7) 7.60 ± 3.62 (6)
Estradiol (pmol/L) 10.9 ± 3.1 (3) 11.6 ± 5.5 (5) 16.4 ± 4.8 (6) 26.4 ± 16.5 (4) 32.5 ± 10.7 (4)
SHBG nmol/L) 94 ± 46 (4) 80 ± 37 (8) 77 ± 44 (10) 52 ± 19 (11) 46 ± 13 (7) 31 ± 8 (2)
PSA (μg/L) 0.024 ± 0.022 (4) 0.038 ± 0.042 (9) 0.077 ± 0.058 (7) 0.216 ± 0.184 (7) 0.369 ± 0.254 (5)
Leptin (μg/L) 14.1 ± 7.3 (4) 14.7 ± 7.9 (9) 14.7 ± 7.3 (11) 9.8 ± 6.0 (11) 8.9 ± 6.8 (9) 13.8 ± 8.0 (2)
Basal LH (IU/L) 0.2 ± 0.1 (6) 0.5 ± 0.3 (10) 2.3 ± 2.9 (13) 6.4 ± 3.5 (11) 11.4 ± 6.1 (9) 15.8 ± 5.8 (4)
ΔLH (IU/L) after GnRH stimulation 3.6 ± 3.3 (4) 8.7 ± 7.9 (7) 10.4 ± 6.6 (6) 36.4 ± 24.4 (6) 25.6 ± 16.2 (3)
  (95% CI for boys with CDP) (5.8 - 14.2) (12.8 - 23.2) (14.4 - 20.4) (16.2 - 25.4)
Basal FSH (IU/L) 1.2 ± 0.6 (6) 2.6 ± 2.6 (10) 5.8 ± 6.1 (13) 19.8 ± 12.4 (11) 30.2 ± 16.8 (9) 32.8 ± 16.3 (4)
ΔFSH (IU/L) after GnRH stimulation 2.3 ± 1.0 (4) 3.5 ± 3.5 (7) 2.1 ± 1.5 (6) 13.9 ± 11.7 (6) 9.2 ± 7.5 (3)
  (95% CI for boys with CDP) ( 0.5 - 2.9) (1.5 - 3.9) (1.7 - 3.3) (2.7 - 5.1)
Inhibin B (pg/mL) 90 ± 25 (4) 93 ± 64 (9) 96 ± 59 (12) 48 ± 52(11) 41 ± 60 (8) 23 (1)
AMH (pmol/L) 558 ± 151 (4) 817 ± 843 (9) 605 ± 342 (7) 238 ± 305 (6) 101 ± 125 (5)
INSL3 (ng/mL) < 0.05 (3) 0.12 ± 0.24 (7) 0.23 ± 0.23 (8) 0.57 ± 0.31 (9) 0.58 ± 0.08 (5) 0.88 (1)
To reduce frequency bias, means or medians were calculated for each subject to get one value for each age interval. 
CDP =  constitutional delay of puberty.
No significant delay in skeletal maturation during puberty occurred in the KS
boys, as evidenced by a strong linear relationship between progression of bone age
and chronological age (Fig. 1D). Only during prepuberty did three boys show a
significant delay in bone maturation of 2.1 to 2.5 years, but it caught up with advancing
age. One boy displayed an advanced BA of 2.4 years before onset of puberty.
Otherwise, BAs of the KS boys fell within the mean ± 2 SD for healthy Finnish boys
during puberty (Ojajärvi 1982) (Fig. 1D).
Changes in hormone levels (I, II, IV)
Development of hypergonadotropism and exaggerated responses to GnRH. To
evaluate the activity of the pituitary-gonadal axis during puberty, both basal
gonadotropin levels and the responses to GnRH stimulation were investigated. From
midpuberty onwards, the 14 KS boys showed a gradual increase in FSH and LH
concentrations to hypergonadotropic levels, FSH levels increasing somewhat earlier
and more markedly than LH levels (Table 2 and Fig. 2). Moreover, the pathologically
accentuated LH and FSH responses to GnRH stimulation developed during




pism in 14 boys with KS during
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Serum testosterone levels during puberty. Longitudinal changes in circulating
testosterone levels in the KS boys and in 41 healthy boys of similar age (Ankarberg-
Lindgren and Norjavaara 2004; Ankarberg-Lindgren 2005) are shown in Figure 3A. The
diurnal rhythm of serum testosterone was taken into consideration by grouping the
samples according to time of day; serum testosterone levels measured from 0747 to
1000 h or after 1000 h (1001-1510 h) were compared separately to those for the
healthy controls measured at 0600 or 1400 h.
KS boys did not have lower serum testosterone levels than did controls in either
group (P = ns), but despite this, some of the older KS boys displayed
hypergonadotropism, as evidenced by elevated (> 6 IU/L) serum LH levels (Fig. 3A). In
comparison with the group of 30 healthy boys with ISS, the KS boys displayed—at
bone age 13 to 14 years and at Tanner stages G4 and P3, and concomitantly with
pathologically high serum LH levels—significantly lower testosterone levels (Table 3);
these, however, still fell within the normal testosterone range for healthy boys
(Ankarberg-Lindgren and Norjavaara 2004).
Longitudinal changes in serum estradiol and estradiol / testosterone ratios
during puberty. Especially before the age 12, the KS boys had higher serum E2 levels





































Lindgren 2005). The E2 samples were also grouped according to time of day;
differences in serum E2 levels were significant in both groups. Before 1000 h, in KS
boys they were 19.0 ± 12.2 pmol/L, n = 8, and in controls 8.8 ± 6.4 pmol/L, n = 28 (P =
0.003). After 1000 h, in KS boys they were 18.0 ± 9.2 pmol/L, n = 12, and in controls
7.3 ± 5.4 pmol/L, n = 28 (P < 0.0001) (Fig. 3B). Differences in E2 / testosterone ratios
(Fig. 3C) between the groups were not significant during prepuberty or puberty, but a
tendency toward higher E2 / testosterone ratios appeared in the KS boys. Before 1000
h, in KS boys they were 15.9 ± 13.3, n = 8; in controls 7.9 ± 8.8, n = 28 (P = 0.05). After
1000 h, in KS boys 13.3 ± 9.1, n = 12; in controls 14.0 ± 9.4, n = 28 (P = ns). During
follow-up, no tendency appeared toward higher E2 levels or higher E2 / testosterone




puberty in 14 boys with KS: A,
serum testosterone (T) in KS
subjects; B , serum 17 -estradiol
(E2) in KS boys; C, E2 / T ratios in
KS boys including those with (in
red) and without serum LH > 6
IU/L. Levels in healthy Swedish
boys (Ankarberg-Lindgren and
Norjavaara 2004; Ankarberg-
Lindgren 2005) were measured,
at 0600 h, 1000 h, and 1400 h.
Longitudinal changes in SHBG, PSA, and leptin during puberty. To evaluate
androgen activity at tissue level, serum SHBG, PSA, and leptin concentrations were
measured. During puberty, serum SHBG levels in KS boys decreased normally, with
levels remaining in the normal range (P = ns) (Fig. 4A). Figure 4B shows longitudinal
changes in serum PSA levels in KS boys; as compared to 25 healthy boys with CDP
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(Raivio et al. 2004; Wickman et al. 2001), both timing and magnitude of rise in serum
PSA in the KS boys were normal (P = ns).
Figure 4.
Longitudinal changes in serum
SHBG concentrat ions (A )
prostate-specific antigen (PSA)
(B), leptin (C), body mass index
(BMI) (D), and leptin / BMI ratio
(E) during puberty in 14 boys with
KS, compared with levels in 25
healthy boys with constitutional
delay of puberty (CDP) (Raivio et
al. 2004; Wickman et al. 2001).
Chronological ages are shown for
boys with KS, and bone ages for
boys with CDP.
Figure 4C shows longitudinal changes in serum leptin levels in the 14 boys with
KS: Levels decreased during puberty, but were on average higher in the KS group than
in healthy CDP controls (KS boys 11.8 ± 7.0 μg/L; controls 7.6 ± 4.7 μg/L, P = 0.03;
Fig. 4C). Mean BMI between these groups did not differ (KS boys 19.0 ± 2.4 kg/m2;
controls 18.7 ± 2.5 kg/m2, P = ns, Fig. 4D). A slight increase in BMI during puberty
appeared in both groups (Fig. 4D). When serum leptin levels were adjusted for BMI,
leptin / BMI ratios declined with advancing puberty in both groups, but the KS boys still
had higher ratios than did controls (KS boys 0.57 ± 0.30; controls 0.39 ± 0.22, P = 0.04,
Fig. 4E).
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Longitudinal changes in inhibin B and AMH during puberty. Serum inhibin B
increased in early puberty, but this initial rise was followed by a rapid suppression
accompanied by a simultaneous increase in serum testosterone (Fig. 5A and Table 2).
A strong, inverse non-linear correlation (rs = -0.57, P < 0.0001) existed between serum
inhibin B and testosterone levels (Fig. 5C). When serum inhibin B levels declined, both
basal FSH and responses to GnRH stimulation became clearly pathological (Table 2).
During prepuberty and early puberty, serum AMH levels were high, but with
advancing puberty, AMH was suppressed simultaneously with inhibin B (Fig. 5B and
Table 2). There also existed a strong, inverse non-linear relationship (rs = -0.66, P <
0.0001) between serum AMH and testosterone levels (Fig. 5D). Before testosterone
had reached 2.5 nmol/L, a marked drop in serum AMH had already occurred (Fig. 5D).
Figure 5.
14 boys with KS. A and B ,
longitudinal changes in serum
inhibin B and serum anti-Müllerian
hormone (AMH). C and D ,
correlations between inhibin B
and testosterone (T), and AMH
and testosterone. Dashed lines =
serum testosterone 2.5 nmol/L.
Longitudinal changes in INSL3 levels. First, changes in serum INSL3 concentrations
during puberty in healthy boys with ISS were characterized. In healthy boys, onset of
puberty was associated with a marked increase in INSL3 levels (from Tanner pubertal
stage 1 to 2) that occurred concurrently with significant increases in T and LH levels
(Table 3). Significant increases in serum INSL3 and LH levels took place between bone
ages 10 to 11 years and 11 to 12 years, and adult INSL3 concentrations 0.55 ng/mL
(Bay et al. 2005) were reached at bone age 13 to 14 years (Table 3).
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 Table 3. Serum concentrations of INSL3, testosterone (T) and LH in 30 healthy boys with idiopathic short stature (ISS) at baseline,
in 14 placebo-treated ISS boys during follow-up, and in 14 boys with Klinefelter syndrome (KS) 
according to bone age and Tanner pubertal stage.
ISS boys KS boys
INSL3 (ng/mL) T (nmol/L) LH (IU/L) INSL3 (ng/mL) T (nmol/L) LH (IU/L)
Bone age (years)
10-11 0.11 ± 0.12 (10) 1.2 ± 1.9 (10) 0.6 ± 0.6 (10) 0.00 (1) 0.9 ± 0.6 (4) 0.5 ± 0.3 (4)
11-12 0.30 ± 0.19 (10) * 2.7 ± 3.0 (9) 1.6 ± 0.8 (10) ** 0.20 ± 0.24 (8) 1.2 ± 0.8 (7) 1.4 ± 1.7 (9)
12-13 0.46 ± 0.25 (7) 6.7 ± 3.7 (5) * 1.6 ± 0.8 (7) 0.55 ± 0.30 (6) * 4.0 ± 5.1 (8) 3.9 ± 4.3 (11)
13-14 0.65 ± 0.14 (3) 13.7 and 14.7 (2) § 3.2 ± 0.8 (3) 0.48 ± 0.40 (6) 5.3 ± 4.6 (7) § 6.5 ± 4.7 (9)
14-15 0.66 ± 0.18 (3) 3.0 ± 1.5 (3) 0.54 ± 0.27 (6) 5.4 and 9.6 (2) 9.9 ± 6.7 (7)
Pubertal stage G
1 0.06 ± 0.05 (25) 0.4 ± 0.2 (25) 0.4 ± 1.5 (25) 0.03 ± 0.04 (6) 0.5 ± 0.3 (7) 0.2 ± 0.1 (7)
2 0.32 ± 0.16 (13) **** 2.1 ± 1.2 (11) **** 1.8 ± 0.9 (13) **** 0.28 ± 0.32 (11) 2.6 ± 3.0 (11) 2.5 ± 3.8 (13)
3 0.45 ± 0.15 (7) 7.5 ± 2.8 (6) 1.7 ± 0.8 (7) 0.47 ± 0.12 (6) 4.9 ± 4.5 (8) 5.1 ± 4.7 (11)
4 0.78 ± 0.22 (6) 15.1 ± 1.6 (3) § 0.7 ± 0.8 (6) §§ 0.59 ± 0.14 (5) 6.3 ± 4.8 (6) § 8.5 ± 4.4 (9) §§
5 0.56 and 0.81 (2) 4.1 and 4.7 (2) 0.68 ± 0.17 (4) 8.8 (1) 14.1 ± 6.3 (4)
Pubertal stage P
1 0.13 ± 0.14 (29) 1.1 ± 1.6 (29) 0.7 ± 0.6 (29) 0.11 ± 0.14 (9) 1.7 ± 2.5 (8) 1.1 ± 2.0 (9)
2 0.37 ± 0.16 (6) *** 3.9 ± 1.6 (4) ** 1.7 ± 0.8 (6) ** 0.45 ± 0.41 (5) * 5.2 ± 5.1 (9) 4.1 ± 4.3 (11)
3 0.83 ± 0.23 (4) 13.7 and 16.9 (2) §§ 2.6 ± 0.8 (4) § 0.59 ± 0.27 (8) 4.8 ± 3.2 (7) §§ 8.8 ± 5.5 (10) * §
4 0.70 ± 0.16 (4) 14.7 (1) 2.9 ± 1.3 (4) 0.63 ± 0.18 (5) 6.6 (1) 11.4 ± 6.9 (5) 
Means ± SD. number of patients (n). Bold indicates INSL3 levels > 0.55 ng/dL, 2.5 percentile in healthy adult men (Bay et. al. 2005)
* and § indicate the stages when differences first became significant between stages within groups or between groups, respectively 
 *, P < 0.05; **, P  < 0.01; ***, P  < 0.001 and ****, P < 0.0001. §, P < 0.05 and §§, P < 0.01
In KS boys in comparison with healthy boys, no significant difference in INSL3
levels emerged in assessment according to bone age or Tanner pubertal stage (Table
3). In the KS boys, the increase in serum INSL3 was significant between bone ages 11
to 12 and 12 to 13 years, and from Tanner pubertal stage P1 to P2 (Table 3). Adult
INSL3 levels (≥ 0.55 ng/mL) were reached at bone age 12 to 13 years. Thereafter,
INSL3 and testosterone concentrations plateaued despite increasing LH levels (Table
3).
Following this, the impact of hypergonadotropism on serum INSL3 levels was
analyzed during hyperandrogenism induced with an aromatase inhibitor in healthy boys
with ISS. The 9 boys that entered puberty within 18 months from the start of Lz therapy
showed a marked increase in serum INSL3 levels from 0.21 ± 0.19 ng/mL (month 0) to
1.15 ± 0.55 ng/mL (24 months), whereas the 8 Pl-treated ISS boys, who entered
puberty during follow-up, showed an increase from 0.08 ± 0.06 ng/mL (month 0) to 0.53
± 0.14 ng/mL (24 months) (Fig. 6). One year after cessation of Lz therapy, a slight
decrease in INSL3 levels was noted to 1.00 ± 0.36 ng/mL (Fig. 6).
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Figure 6.
Serum INSL3, LH, and
testosterone (T) concentrations
(mean ± SD) in healthy boys with
idiopathic short stature treated for
24 months with placebo (Pl, n = 8)
or with letrozole (Lz, n = 9). P -
values, differences between the
groups.
After this study, two of the KS boys (6KS and 7KS) were started on
testosterone substitution therapy, and after 6 months on testosterone (Sustanon
“250”®, Organon, Oss, Netherlands) 1 mg/kg every fourth week, their serum INSL3
decreased from 0.68 ng/mL to 0.11 ng/mL and from 0.49 ng/mL to 0.04 ng/mL. At the
same time, their serum LH levels decreased from 21.3 IU/L to 4.1 IU/L and from 17.0
IU/L to 1.4 IU/L.
Correlations of INSL3 levels during puberty. Furthermore, study of relationships of
INSL3 levels to testicular volume, serum LH, testosterone, and inhibin B levels showed
that in the KS boys significant correlations appeared between INSL3 and testicular
volume, LH, testosterone, and inhibin B concentrations, as they did also in both the Pl-
and Lz- treated ISS boys (|r| = 0.60-0.90, P < 0.0001). As testicular volumes in the KS
boys never exceeded 4.5 mL, they displayed higher INSL3 / testicular volume ratios
than did ISS boys (P < 0.0001). The KS boys displayed low INSL3 levels when the
hypergonadotropism with high LH levels occurred; this difference in INSL3 / LH ratios
from those of the healthy boys was significant (P < 0.0001). In INSL3 / testosterone
correlations, the differences between these two groups were non-significant (P = 0.07).
Furthermore, the KS boys showed an inverse correlation between INSL3 and inhibin B
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(r = –0.63, P < 0.0001) because after onset of puberty secretion of inhibin B was very
rapidly suppressed.
Figure 7.
Healthy boys with ISS (placebo-
treated) and boys with KS; in both
groups significant (P < 0.0001)
correlations: A, between serum
INSL3 levels and testicular
volume; B , between INSL3 and
LH; C , between INSL3 and
testosterone (T), and D, between
INSL3 and inhibin B levels. Linear
regression lines are shown.
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Table 4.  Histomorphometric analyses of testicular biopsies of 14 boys with KS, with key characteristics at the time of the biopsy.
Patient Group Age Tanner Mean testicular Ap + Ad Ad Sertoli cells Leydig cell Interstitium and
number number (years)  stage volume spermatogonia/ spermatogonia/ type hyperplasia peritubular
(mL) tubule tubule connective tissue
1KS I 10.1 P1/G1 1.1 1.2 0.01 Sa/Sb 0 fibr (+)
2KS I 10.1 P1/G1 1.3 0.04 0 Sa/Sb 0 fibr +, hyalin
3KS I 10.3 P1/G1 0.8 0.8 0.006 Sa/Sb 0 fibr (+)
4KS I 10.7 P1/G1 1.6 1.0 0.03 Sa/Sb + fibr ++
5KS I 11.6 P1/G1 1.0 0.1 0.01 Sa/Sb, pale 0 fibr +
6KS I 11.9 P1/G1 1.8 1.2 0.01 Sa/Sb 0 fibr +, hyalin
7KS I 12.5 P2/G2 1.7 1.2 0.03 Sa/Sb 0 fibr +, hyalin
9KS I 11.9 P1/G2 2.5 + + Sa/Sb, degen 0 fibr +
10KS I 13.0 P1/G2 1.8 + + Sa/Sb, degen + fibr ++, hyalin
12KS I 13.7 P1/G2 3.4 + + pale, degen +++ fibr ++
8KS II 11.7 P1/G2 2.0 0 0 Sa/Sb 0 fibr (+)
11KS II 11.8 P2/G2 3.9 0 0 Sa, pale, degen ++ fibr ++, hyalin
13KS II 14.0 P2/G2 3.2 0 0 pale, degen +++ fibr +++, hyalin
14KS II 14.0 P3/G4 3.1 0 0 pale, degen, hyalin ++++ fibr +++, hyalin
+; presence of spermatogonia detected by MAGE-A4 staining (V), but not by morphological inspection (I). 0; no spermatogonia detected.
Patients are divided into two groups according to presence or absence of spermatogonia. Puberty staged according to Tanner. Ap (pale adult) and 
Ad (dark adult) spermatogonia counts per cross-section of seminiferous tubule. Sertoli cells staged as Sa, Sb, pale, and degenerating. The degree of 
Leydig cell hyperplasia staged 0  to ++++. The degree of fibrosis of the interstitium is staged (+) to +++ and presence of hyalinization is marked "hyalin".
MORPHOLOGICAL DEGENERATION OF THE TESTIS (I,V)
Histomorphmetric analyses
Results of histomorphometric analyses of the biopsy specimens, as well as the key
characteristics of the 14 patients at the time of the first testicular biopsy are presented
in Table 4. Representative specimens from five KS boys and from one boy with a
normal karyotype are shown in Figure 8. The subjects were divided into two groups
according to the presence (group I) or absence (group II) of germ cells from the biopsy
specimens.
Germ cells. On morphological inspection, spermatogonia of the adult pale type (Ap)
appeared in 7 of 14 and of the adult dark (Ad) type in 6 of 14 biopsy specimens (Table
4). The second biopsy specimens taken from patients 8KS to 10KS from the
contralateral testis 1.0 to 1.6 years after the first specimens failed also to show any
germ cells in histomorphometric analyses. In the immunohistochemical analyses,
however, spermatogonia were detected by MAGE-A4 staining also in the samples of
patients 9KS, 10KS, and 12KS (Tables 4 and 6). In the histomorphometric analyses,
the average number of Ap spermatogonia per seminiferous tubule was reduced: mean
number of Ap spermatogonia was 0.77 (range, 0.04-1.17), and average number of Ad
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Table 5.  Serum homone concentrations of 14 boys with KS at the time of testicular biopsy.
Patient Group FSH LH Testosterone inhibin B AMH
number number (IU/L) (IU/L) (nmol/L) (pg/mL) (pmol/L)
1KS I 0.1 0.1 0.3 103 503
2KS I 1.0 0.2 0.3 78 758
3KS I 1.5 0.1 0.3 66 345
4KS I 1.9 0.4 0.3 127 606
5KS I 1.0 0.3 0.8 68 1156
6KS I 1.5 0.5 0.8 75 803
7KS I 1.1 0.5 1.1 69 1062
9KS I 0.5 0.2 0.3 166 1251
10KS I 0.7 0.1 0.5 97 878
12KS I 17.9 6.9 3.9 29 101
8KS II 1.3 0.5 0.7 301 2658
11KS II 7.5 1.2 2.3 <15.6 81
13KS II 33.2 9.7 15.7 <15.6 96
14KS II 38.6 11.4 10.2 <15.6 16
Patients are divided into two groups according to precense or absence of spermatogonia (see Table 4). 
spermatogonia per tubule was 0.01, whereas all normal controls had consistently more
than 0.46 (mean 1.5) Ad spermatogonia per tubule (P < 0.001). No pachytene
spermatocytes or post-meiotic spermatids appeared in any of the biopsy specimens of
the KS subjects. Furthermore, at the time of cryopreservation of testicular tissue, no
spermatozoa were visible in any of the specimens.
Sertoli cells, Leydig cells and interstitial tissue. In the biopsy specimens of patients
1KS to 10KS, the Sertoli cells were of Sa and Sb type and exhibited a relatively normal
appearance (Table 4, and Figs. 8A and B, and 9). However, marked degeneration of
Sertoli cells was evident in patients 11KS to 14KS (Table 4, Figs. 8C and D). Boys 1KS
to 10KS had Leydig cells of juvenile type that showed none or only moderate
hyperplasia, whereas the older subjects 11KS to 14KS had huge hyperplastic Leydig
cells (Table 4, Figs. 8C and D). Fibrosis and hyalinization of the interstitium and
peritubular connective tissue were visible in all groups; in addition, these signs of
degeneration increased with age (Table 4). Figures 8 A to D show differing degrees of
the degeneration process. This degeneration was not uniformly detectable throughout
the relatively small biopsy specimens, whereas within the same biopsies, some areas
showed marked degeneration and some areas only moderate changes (Fig. 8E).
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Figure 8. Testicular biopsies of five adolescent boys with KS from Table 4, and one normal boy. Stain =
Toluidine blue. A. Patient 4KS, two types of seminiferous tubules identifiable: those with no spermatogonia
on the right and those with spermatogonia of adult pale type (Ap) on the left. “Ad” indicates spermatogonia
of adult dark type. Sertoli cells: Sa and Sb type. Leydig cells: juvenile type, some hyperplasia. Interstitium:
increased fibrosis. x 400. B. Patient 8KS, no spermatogonia. Sertoli cells: Sa and Sb type. Leydig cells:
juvenile type. Interstitial compartment appears normal. x 400. C. Patient 12KS, no spermatogonia. Sertoli
cells: Sa and Sb type, pale and degenerative. Interstitial compartment: increased volume, hyperplastic
Leydig cells, and some fibrosis. x 400. D. Patient 14KS, seminiferous tubules completely hyalinized.
Interstitial compartment: hyperplastic Leydig cells and extensive fibrosis. x 400. E. Patient 7KS, centrally
seminiferous tubules with Ap or Ad spermatogonia or both. This area is surrounded by tubules in which the
degeneration process is evident: tubules with pale degenerative Sertoli cells and small tubules with dark
small apoptotic cells. x 200. F. Normal control, age 11 yrs, testicular biopsy taken at surgical exploration
because of scrotal pain. x 200.
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Figure 9.
Patient 2KS, group I (Table 4). Electron
micrograph of testicular biopsy of boy with
KS at age 10.1 yrs and Tanner stage
P1G1. Undifferentiated Sertoli cells
resembling Sa type with a round nucleus
with a small nucleolus lacking lamellar
body, and with crystalloids from Charcot-
Bötscher (1). In the center, one
degenerating Sertoli cell (2). x 2500.
Immunohistochemical analyses
Expression of markers for germ cell differentiation. Expression of AP-2 (TFAP2C,
transcription factor activator protein-2) and OCT-3/4 (also known as POU5F1, a POU-
family transcription factor) was analyzed in the seven youngest KS patients (1KS-7KS)
and in the youngest controls (1C and 2C). None of the markers showed any expression
in these sections, whereas the positive control sections of testicular CIS were, as
expected, strongly positive.
Then three established markers of spermatogonia: MAGE–A4 (Melanoma
antigen-encoding gene-A4), NY-ESO-1 (CTAG1B/LAGE), and CHK2 (Chek2) (Table 6)
were analyzed. MAGE-A4 was expressed in all spermatogonia in both KS and control
specimens (Table 6 and Fig. 10A). In contrast, only a subset of spermatogonia was
positive for CHK2 (40-80% of spermatogonia positive) and NY-ESO-1 (0-50% positive)
(Table 6 and Figs. 10B and C). Spermatogonia were detected by MAGE-A4 staining
even in samples (patients 9KS, 10KS, and 12KS) which by morphological inspection
were judged to be negative for germ cells (I). Furthermore, some tubules with no
apparent germ cells showed nonspecific expression of MAGE-A4 (Fig. 10A). No
differences between KS and control samples were evident in intensity of expression of
the X-linked markers MAGE-A4, NY-ESO-1, and MIC2 (Table 6 and Fig. 10)
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Table 6. Immunoexpression of markers for spermatogonia (spg) and Sertoli cells in testicular biopsies of 14 prepubertal and
pubertal boys with KS and in age-matched control boys (C)
Patient Markers
Age CHK2 MAGE-A4 NY-ESO-1 MIC-2
(years) % % %
1KS 10.1  ++ / ± 50%  ++ 100% ± 30-50% 0
2KS 10.1  ++ / ± 50%  ++ 100% ± 30-50% 0
3KS 10.3  ++ / ± 50%  ++ 100% ± 30-50% 0
4KS 10.7  ++ / ± 70%  ++ 100% ± 30-50% 0
5KS 11.6  ++ / ± 70%  ++ 100% ± 30-50% 0
6KS 11.9 + / ± 70%  ++ / + 100% ± 30-50% 0
7KS 12.5  ++ / ± 50%  ++ 100% ± 30-50% no spg
8KS 11.7 n.a. no spg no spg no spg
8KS 12.8 no spg no spg no spg no spg
9KS 11.9 n.a.  +, few 100% 0 0% 0
9KS 12.9 no spg  ++, few 100% 0 0% no spg
10KS 13.0 n.a.  +, few 100% 0 0% 0
10KS 14.6  ++ / ±  ++, few 100% ± 30-50% 0
11KS 11.8 n.a. no spg no spg no spg
12KS 13.7 no spg  ++, few 100% 0 0% no spg
13KS 14.0 n.a. no spg no spg no spg
14KS 14.0 no spg no spg no spg no spg
1C 7.5  ++ / ± 80%  ++ 100% 0 0% 0
2C 7.5 + / ± 70%  ++ / + 100% ± 30-50% 0
3C 7.5  ++ / ± 80%  ++ 100% + / ± 30-50% 0
4C 8.5 n.a. n.a. n.a. 0
5C 9.5 + / ± 80%  ++ 100% 0 0% 0
6C 9.5  ++ / ± 80%  ++ 100% 0 0% 0
7C 11.0 n.a. n.a. n.a. 0
8C 11.0 + / ± 50%  ++ 100% + / ± 30-50% 0
9C 11.5 + / ± 70%  ++ 100% + one spg 0
10C 12.0 + / ± few  ++ / + 100% no spg 0
11C 13.0 n.a. n.a. n.a. 0
12C 15.5 n.a. n.a. n.a. 0
13C 16.5 + / ± 40%  ++ / + 100% ± 30-50% 0
Adult normal testis  ++ / ± 50-100% ++ 100% + / ± 50-70% 0
Score: ++; strong staining, +; intermediate staining,  ±; weak staining, 0; no specific staining detected
%, approx. % positive spg detected in the section; n.a., not analyzed
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Figure 10. Markers for spermatogonia in testicular biopsies of boys with KS. See Table 6 for details. A,
MAGE-A4 expression: seminiferous tubules with strongly stained spermatogonia (spg) and SCO tubules
with unspecific or no staining (patient 1KS). B, CHK-2 expression (patient 4KS). C, NY-ESO-1 expression
(patient 7KS). D, MIC2 expression: strongly stained Sertoli cells showing spermatogonia as white spots
(patient 5KS). Magnification x 200.
Expression of AMH. Down-regulation with age of AMH expression in Sertoli cells
occurred both in KS and in controls, but this event occurred at an older age in KS
(Table 7 and Figs. 11A and B). A more heterogeneous picture appeared in both groups
with decreased expression, with stronger staining in some tubules, whereas others




Table 7.  Immunoexpression of markers for Sertoli and Leydig cells in testicular biopsies of 14 prepubertal and pubertal boys
with KS and of age-matched controls (C)
Patient Markers
Age AMH Inhibin alpha-subunit Inhibin betaB-subunit Androgen receptor (AR)
(years) Sertoli cells Sertoli cells Leydig cells* Sertoli cells Leydig cells* Sertoli cells Leydig cells*
1KS 10.1 ++ ++ 0 + 0 N:  ++ / ± (0-75%), C: ± / 0 N: 0,  C: 0
2KS 10.1 ++ / ± ++ / ± 0 ± 0 N:  ++ / + (10-75%), C: ± / 0 N: ± / 0 (33%), C: 0
3KS 10.3 ++ / + ++ 0 + 0 N:  ++ / ± (10-75%), C: ± / 0 N: ± / 0, C: 0
4KS 10.7 + / ± ++, N+ 0 ± 0 N:  ++ / ± (33-100%), C: ± / 0 N: ± / 0, C: 0
5KS 11.6 ++ / + ++ ± + 0 N:  ++ / ± (10-75%), C: ± / 0 N: ± / 0, C: 0
6KS 11.9 + ++, N+ ± ± 0 N:  ++ / ± (10-50%), C: ± / 0 N: ±, C: 0
7KS 12.5 ++ / + ++ / ± 0 ± 0 N:  ++ / ± (10-100%), C: ± / 0 N: ± / 0, C: 0
8KS 11.7 + / ± ++ / ±, N+ ± + 0 N:  ++ / ± (10-75%), C: ± / 0 N: ± / 0, C: 0
8KS 12.8 ± + /±, N+ 0 ± 0 N:  ++ / ± (20-100%), C: ± / 0 N: ± / 0 (50%), C: 0
9KS 11.9 ++ / ± ++ / +, N+ 0 + 0 N:  ++ / ± (10-75%), C: ± / 0 N: ± / 0, C: 0
9KS 12.9 ± + , N+ 0 + ± N:  ++ / ± (40-100%), C: ± / 0 N: + / 0 (20%), C: 0
10KS 13.0 + / ± + 0 ± 0 N:  ++ / ± (5-50%), C: ± / 0 N: ± / 0, C: 0
10KS 14.6 + / ± ++ / +, N+ ± + + N:  + / ± (5-60%), C: ± / 0 N: ± / 0 (20%), C: 0
11KS 11.8 0 ±, N+ ± + ± N:  ++ / + (80-100%), C: ± / 0 N: + / ± (60%), C: ±
12KS 13.7 + / ± +, N+ ± + ± N:  ++ / + (80-100%), C: ± / 0 N: + / ±, C: ±
13KS 14.0 trace +, N+ ± + 0 N:  ++ / ± (80-100%), C: ± / 0 N: + / ±, C: ±
14KS 14.0 0 ± ++ + + N:  ++ / + (90-100%), C: ± / 0 N: ++ / + (60%), C: ++ / ±
1C 7.5 + / ± + / ± 0 ± 0 N:  ++ / ± (10-75%), C: ± / 0 N: ± (20%), C: 0
2C 7.5 + / ± ++ 0 ± ± N:  ++ / ± (5-80%), C: ± / 0 N: ± (30%), C: 0
3C 7.5 + / ± n.a. n.a. n.a. n.a. N:  ++ / ± (10-75%), C: ± / 0 N: ± / 0, C: 0
4C 8.5 + / ± n.a. n.a. n.a. n.a. N:  ++ / ± (20-80%), C: ± / 0 N: ± / 0, C: ±
5C 9.5 + / ± n.a. n.a. n.a. n.a. N:  ++ / ± (60-100%), C: ± / 0 N: ± / 0 (30%), C: 0
6C 9.5 trace n.a. n.a. n.a. n.a. N:  ++ / ± (50-90%), C: ± / 0 N: ± / 0, C: 0
7C 11.0 ± n.a. n.a. n.a. n.a. N:  ++ / ± (50-90%), C: ± / 0 N: ± / 0 (30%), C: 0
8C 11.0 0 n.a. n.a. n.a. n.a. N:  ++ / + (90-100%), C: 0 N: + / ±, C: 0
9C 11.5 0 n.a. n.a. n.a. n.a. N:  ++ / + (90-100%), C: 0 N: + / ± (40%), C: 0
10C 12.0 0 n.a. n.a. n.a. n.a. N:  ++ / ± (90-100%), C: 0 N: + / ± (40%), C: 0
11C 13.0 trace n.a. n.a. n.a. n.a. N:  ++ / + (90-100%), C: 0 N: + / ±, C: 0
12C 15.5 0 ++ ± ± 0 N:  ++ / + (100%), C: 0 N: ++ / + (60%), C: 0
13C 16.5 0 ++ + ± ± N:  ++ / + (100%), C: 0 N: +, C: ±
Adult normal testis 0 ++ / + ++ + / ± ++ / + N:  ++ / + (100%), C: 0 N: + (40%), C: ±
Remarks In older patients Spermatogonia Heterogeneous Weaker staining in tubules with
heterogeneous containing tubuli staining, strongest Sertoli cells not fully differentiated 
more weakly stained in central part
especially in KS
* Leydig cells (more or less differentiated) or interstitial cells. N, nucleus; ;  C, cytoplasma; n.a., not analyzed; (%), approx. % postive nuclei
Score: ++; strong staining, +; intermediate staining,  ±; weak staining, 0; no specific staining detected
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Figure 11. Expression of AMH and inhibin B subunits in testicular biopsies of adolescent boys with KS.
See Table 7 for details. A, AMH expression; strong uniform staining of all seminiferous tubules (patient
1KS). B, AMH expression; heterogeneous staining of SCO tubules (patient 6KS). C, inhibin -subunit
expression; note the strong staining of Sertoli cells in SCO tubules and weaker staining in tubules with
spermatogonia in the lower left (patient 9KS). D, inhibin -subunit expression; note the nuclear staining of
some Sertoli cells (patient 10 KS, second biopsy). E, inhibin B-subunit expression (patient 3KS). F,
inhibin B-subunit expression (patient 10 KS, second biopsy). Magnification x 200.
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Figure 12. Expression of the androgen receptor in testicular biopsies of adolescent boys with KS and age-
matched controls. See Table 7 for details. A, spermatogonia containing tubules identifiable at the right
(patient 3KS). B, control 6C. C, a few spermatogonia-containing tubules identifiable in the center (patient
7KS). D, note nuclear staining of both Sertoli and Leydig cells (control 9C). E, AR predominantly in nuclei
of Sertoli cells with only weak cytoplasmic staining, but note the abundant cytoplasmic expression in
Leydig cells, with varying nuclear expression (patient 14KS). F, control 13C. Magnification x 200.
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Expression of inhibin B subunits. Immunoexpression of the inhibin a-subunit in
Sertoli cells was relatively weaker in the older KS patients than in the younger ones
(Table 7 and Figs. 11C and D). The majority of the KS samples (10 of 17), especially
those from the older boys, showed clear nuclear staining (Fig. 11D); this nuclear
expression was absent from all of the control samples. The Sertoli cells in tubules
containing spermatogonia were less intensively stained than were those in the SCO
tubules (Fig. 11C), a staining pattern of tubules also seen in controls, but one not as
marked as in some of the KS samples. Expression of the inhibin a-subunit also
appeared in Leydig cells (Table 7 and Fig. 11D).
In contrast to the expression of the a-subunit, expression of the inhibin bB-
subunit expression in Sertoli cells remained stable in all KS specimens regardless of
age (Table 7 and Figs. 11E and F).
Expression of the androgen receptor (AR). Both in KS and controls the number of
Sertoli cell nuclei expressing AR increased with age, but the proportion of stained
nuclei was greater in the age-matched controls (Table 7 and Fig. 12). Expression was
weaker in tubules containing not yet fully mature Sertoli cells, although no constant
difference in intensity was evident in the KS samples between SCO tubules and
seminiferous tubules containing germ cells (Figs. 12A and C). Weak cytoplasmic
staining was detectable in Sertoli cells of all KS samples, but detectable in only the
youngest control patients (age ≤ 11.0 years) (Table 7). Nuclear expression of AR in
Leydig cells and interstitial precursor cells in the young patients in both groups was
similar (Table 7 and Figs. 12A-D). In contrast to the controls, the older KS patients
showed very strong AR expression both in the nuclei and cytoplasm of their Leydig
cells (Table 7 and Figs. 12E and F).
Correlations between histological findings and serum hormone levels
Correlations between serum reproductive hormone levels and findings of the testicular
biopsy specimens were investigated to find whether hormone levels predict the
presence or absence of germ cells. The 10 KS boys with spermatogonia detected with
MAGE-A4 immunostaining of their first testicular biopsy had smaller testicular volumes
(1.7 ± 0.8 vs. 2.9 ± 0.8 mL, P = 0.02), lower serum testosterone (0.9 ± 1.1 vs. 7.2 ± 7.0
nmol/L, P = 0.03), lower serum FSH (2.7 ± 5.4 vs. 20.2 ± 18.5 IU/L, P = 0.04), and
lower serum LH (0.9 ± 2.1 vs. 5.7 ± 5.7 IU/L, P = 0.02) levels than did the four KS boys
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with no spermatogonia present (Fig. 13). No differences between these two groups
were detectable in serum inhibin B levels (87.8 ± 38.9 vs. 87.0 ± 142.7 pg/mL, P = ns)
and AMH (746 ± 365 vs. 713 ± 1297 pmol/L, P = ns) at the time of the first testicular
biopsy (Fig. 13). Patient 8KS constituted an exception; in the testicular biopsy
specimens of all KS patients with measurable inhibin B levels ( 15.6 pg/mL), germ
cells were detectable, but in his testicular biopsy specimens, although obtained twice at
an interval of 1.1 years, none were detectable. On both occasions his inhibin B (301
and 118 pg/mL) and AMH (2658 and 477 pmol/L) serum levels were normal. If subject
8KS is excluded from the analysis (n=13), then inhibin B levels (87.8 ± 38.9 vs < 15.6
pg/mL, P = 0.01) and AMH levels (746 ± 365 vs. 64.3 ± 42.5 pmol/L, P = 0.01) were
predictive for the presence (n=10) or absence (n=3) of germ cells.
Serum AMH level decreased (Fig. 5B) concomitantly with its immunoexpression
in the testes (Table 7 and Figs. 11A and B). Serum inhibin B levels decreased (Fig.
5A), but expression of both subunits remained detectable in the immunohistochemical
analyses despite circulating inhibin B concentrations’ being undetectable (Table 7, and
Figs. 11 C-F).
Figure 13.
Testicular volume and serum
hormone levels correlated with the
presence of germ cells in
testicular biopsies of 14 KS boys
(mean age 11.9, range 10.1-14.0
year). +, germ cells detected, n =
10; -, not detected, n = 4. Means
for groups indicated by horizontal
lines. Tvol = Testicular volume; T
= testosterone.
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Table 8. Genetic data of 14 nonmosaic 47,XXY boys
Patient Origin of extra Number of Inactivity ratio Preferentially Arithmetic mean of X-weighted biallelic
X chromosome CAG repeats short: long allele active allele CAG repeats mean of CAG repeats
1KS M I 17 : 17 17
2KS M I 19 : 22 69 : 31 long 20.5 21.1
3KS M II 26 : 26 26
4KS M I 19 : 26 18 : 82 * short 22.5 20.2
5KS M II 22 : 22 22
6KS M II 22 : 22 22
7KS M I 22 : 24 69 : 31 long 23 23.4
8KS P 20 : 21 17 : 83 * short (P) 20.5 20.2
9KS M II 26 : 26 26
10KS P 20 : 22 32 : 68 short (P) 21 20.6
11KS M II 20 : 20 20
12KS P 24 : 24 24
13KS M I 22 : 22 22
14KS M I 20 : 21 50 : 50 20.5 20.5
M I =  first maternal meiosis; M II =  second maternal meiosis; P = paternal; * = skewed X chromosome inactivation
GENETIC MECHANISMS OF GONADAL FAILURE (III)
The impact on the phenotypes in Table 9 of all genetic features of the X chromosome
listed in Table 8 was investigated. LH and testosterone levels clearly exceeding
prepubertal levels were biochemical markers of onset of puberty.
Parental origin of the supernumerary X chromosome. The origin of the X
chromosomes was unambiguously assigned for all cases (Table 8). Although the
sample from his father was not available for patient 13KS, his supernumerary X
chromosome was assigned as maternal, because all marker alleles of the proband
were maternal. The extra X chromosome was paternal in 3 (21%) and maternal in 11
(79%) cases.
The parental origin of the supernumerary X chromosome did not influence the
growth during childhood (ages 2-9 years). Relative heights in this period were 0.63 ±
1.03 SD and -0.19 ± 0.54 SD for the 47,XmXmY and 47,XmXpY boys. Predicted adult
heights were 1.47 ± 1.05 SD and 1.34 ± 0.79 SD for subjects with 47,XmXmY and
47,XmXpY, respectively. Furthermore, no difference existed in body composition
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Table 9. Phenotypes investigated in 14 boys with KS
Growth
Mean height (SD) between ages 2 to 9 years, related to target height 
Predicted adult height (SD), related to target height
Body composition during puberty (mean BMI after age 10 years)
Onset of puberty
Clinical markers: Age at Tanner stage P2
Age at testicular volume 2.0 mL
Hormonal markers: Age at serum LH ≥ 1.0 mL
Age at serum testosterone ≥ 1.0 nmol/mL
Progression of puberty
Age at acceleration of velocity (take-off) in height growth
Age at peak velocity in height growth
Chronological age at bone age (BA) 12.0 years
Testicular degeneration
Age at serum FSH ≥ 10.0 IU/L
Age at serum LH ≥ 10.0 IU/L
Age at serum inhibin B ≤ 32 pg/mL
between these two groups during puberty (BMI after age 10: 47,XmXmY, 19.6 ± 2.6 and
47,XmXpY, 17.5 ± 0.8).
The onset and progression of puberty was delayed in the 47,XmXpY boys when
compared to the 47,XmXmY boys, as indicated by clinical markers and serum hormone
measurements (Fig. 14). Tanner stage P2 was noted at age 12.5 ± 0.7 years in the
47,XmXmY boys, and at 13.9 ± 1.4 years in the 47,XmXpY boys (P = 0.09) (Fig. 14A); the
same trend was seen for the increase in testicular size (P = ns) (Fig. 14B). There
occurred a later increase in serum LH concentration in boys with a 47,XmXpY
karyotype; LH rose above 1.0 IU/L at age 12.5 ± 0.6 years in the 47,XmXmY and at 13.8
± 1.0 years in the 47,XmXpY boys (P = 0.04) (Fig. 14C). A similar trend appeared for
testosterone (P = ns) (Fig. 14D). As signs of a slower progression of puberty, the
pubertal acceleration (take-off) in height velocity (47,XmXmY 11.9 ± 0.5 years; 47,XmXpY
13.8 ± 0.8 years; P = 0.01) and peak velocity in height growth (47,XmXmY 13.2 ± 0.6
years; 47,XmXpY 14.5 ± 0.8 years; P = 0.02) occurred later in the 47,XmXpY subjects
(Figs. 14E and F). The 47,XmXpY boys were also older when they reached bone age 12
yr (47,XmXmY 11.9 ± 0.8 years; 47,XmXpY 13.5 ± 0.6 years; P = 0.03) (Fig.14G). Since
the pubertal increase in reproductive hormones is closely associated with acceleration
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of the testicular degeneration process in KS subjects (I), the 47,XmXpY boys had a later
appearance of testicular degeneration.
Figure 14. Parental origin of the extra X chromosome;
influence on markers for age (years) at onset and
progression of puberty in boys with KS. M = maternal, P =
paternal. T = testosterone. Means for the groups also
shown.
X chromosome isodisomy / heterodisomy. Judged by the microsatellite loci, 5 of the
11 boys with maternally derived extra X chromosome displayed uniparental X
chromosome isodisomy (M II, Table 8). X chromosome isodisomy / heterodisomy did
not influence the phenotypes listed in Table 9.
X chromosome inactivation. X inactivation status could be determined for 6 of the 14
subjects (43%), the remainder being homozygous for the AR gene CAG repeat (Table
8). Patients 4KS and 8KS showed skewed X inactivation, their ratios being 18:82 and
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17:83 (Table 8). No significant differences in the phenotypic features listed in Table 9
were apparent between subjects with or without skewed X inactivation.
CAG repeat length. The lengths of the AR gene CAG repeat varied within the normal
range, being from 17 to 26 (Table 8). No association was observable between the
origin of the supernumerary X chromosome and the length of the CAG repeats (Table
8). Thus, for investigation of the influence of CAG repeat lengths on the phenotype, the
47,XmXpY boys were excluded from these analyses, because of the major impact of the
origin of that extra X chromosome. Spearman’s rank correlations were calculated
between CAG repeat lengths and the phenotypic features listed in Table 9. CAG repeat
lengths did not influence the growth characteristics in Table 9.
Figure 15. X-weighted biallelic mean of A R gene CAG
repeat length; correlations with markers for age (years) at
onset and progression of puberty (A-D), and testicular
degeneration (E-G). T = testosterone. Linear regression lines
shown.
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The CAG repeat length correlated with the hormonal markers for onset of
puberty; boys with longer CAG repeats showed later increases in serum LH and
testosterone levels (CAG length vs age at LH ≥ 1.0 IU/L; rs = 0.63, P = 0.06, n = 10;
and CAG length vs age at testosterone ≥ 1.0 nmol/L; rs = 0.78, P = 0.02, n = 10) (Figs.
15A and B). No evident association appeared between CAG repeat length and the
clinical markers for onset of puberty.
Progression of puberty as indicated by age at take-off (rs = 0.70, P = 0.05, n =
9) and age at peak velocity in height growth (rs = 0.58, P = 0.10, n = 9) tended to be
slower in boys with a longer CAG repeat length (Figs. 15C and D). Furthermore, in
those boys, testicular degeneration occurred later, as indicated by a slower increase in
serum FSH and LH levels to hypergonadotropic levels over 10.0 IU/L (FSH; rs = 0.65, P
= 0.05, n = 10, and LH; rs = 0.94, P = 0.04, n = 6) (Figs. 15E and F), and a slower




This prospective study comprised a longitudinal follow-up of growth, pubertal
development, and serum reproductive hormone levels in 14 prepubertal and pubertal
KS boys, aged 10.0 to 13.9 years at the start of the study. Each boy had a testicular
biopsy specimen taken, which was cryopreserved for possible future use in assisted
reproduction in adulthood. A small part of each specimen was thoroughly analyzed by
histomorphometric and immunohistochemical methods. The impact of genetic features
of the supernumerary X chromosome on growth, pubertal development, and testicular
degeneration was also studied.
KS is the most common genetic form of male hypogonadism, but the complete
clinical phenotype does not appear until after puberty and sometimes may never be
fully expressed. The present study confirmed that during childhood and even during
early puberty, pituitary-gonadal function in 47,XXY subjects is relatively normal. It
showed that rate of pubertal progression in KS boys, as assessed by Tanner P and G
stages, was normal. These results are in agreement with previous findings (Ratcliffe
1999; Salbenblatt et al. 1985; Sorensen 1992; Stewart et al. 1986; Topper et al. 1982).
In addition, onset of puberty as judged by the appearance of pubic hair and initial
testicular enlargement was normal. In the 47,XXY boys, skeletal maturation also fell
within the normal range for healthy Finnish boys (Ojajärvi 1982). Thus, no phenotypic
evidence was found for androgen deficiency in boys with KS during early and
midpuberty.
Circulating serum testosterone levels in these KS boys did not differ from those
in the control boys during early puberty, but from midpuberty onwards their
testosterone levels were in the low-normal range, in agreement with the normal
progression of puberty, and with data from others (Salbenblatt et al. 1985; Stewart et
al. 1986; Topper et al. 1982). Only two studies on KS boys have demonstrated
diminished testosterone secretion before puberty (Lahlou et al. 2004; Ross et al. 2005),
but comprised only infant KS boys. However, circulating testosterone concentrations do
not necessarily reflect androgen activity at tissue level. To address this question, serum
levels of SHBG, PSA, and leptin were measured, the concentrations of which all are, at
least to some extent, regulated by androgens. In the KS boys, serum SHBG decreased
normally, and the levels did not differ from those observed in the controls. During
puberty, serum PSA levels are in healthy boys a potential marker of testosterone
activity. (Juul et al. 1997; Kim et al. 1999; Randell et al. 1996; Vieira et al. 1994). The
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normal increase in serum PSA during puberty in the KS boys suggests sufficient
androgen action in the prostate. Thus, as assessed by serum SHBG and PSA
measurements, the KS boys displayed no evidence of diminished androgen action at
cellular level.
A time- and dose-dependent decrease in leptin production occurs in human
adipocytes exposed to testosterone (Wabitsch et al. 1997). During puberty, serum
leptin levels decrease in close correlation with increasing testosterone levels
(Ankarberg-Lindgren et al. 2001; Blum et al. 1997; Garcia-Mayor et al. 1997). Wabitsch
et al. (1997) have shown that the leptin / BMI ratio is a good indicator of androgen
action. The KS boys had higher leptin and higher leptin / BMI ratios than did control
boys, suggesting diminished androgen action in adipose tissue. This does not,
however, unequivocally reflect deficient androgen action, since serum leptin levels are
also regulated by factors other than testosterone; e.g. one cannot exclude an impact of
elevated E2 levels on serum leptin levels in KS boys.
No signs of hypergonadotropism were detectable in the KS boys during
prepuberty or early puberty. After midpuberty, however, concomitantly with elevations
in basal FSH and LH levels, their response to GnRH stimulation became abnormal.
These observations are in agreement with earlier findings (Salbenblatt et al. 1985;
Stewart et al. 1986; Topper et al. 1982) and suggest diminished testicular inhibition of
gonadotropin secretion. In addition, after midpuberty the boys with KS developed low
testosterone / LH ratios. Such changes in activity of the hypothalamic-pituitary-
testicular axis thus probably represent a state of compensated hypergonadotropic
hypogonadism attributable to the diminished responsiveness of Leydig cells to LH with
advancing puberty.
INSL3, a new marker for Leydig cell function, has been suggested to be more
sensitive than is testosterone to Leydig cell dysfunction and differentiation status (Bay
et al. 2005; Bay et al. 2006; Foresta et al. 2004). The present study, like the cross-
sectional one by Ferlin et al. (2006), showed a continuous increase in INSL3 levels
during puberty in healthy boys, which provides an opportunity to use INSL3 as a Leydig
cell-specific marker for the onset and progression of puberty. Furthermore, the
dependence of INSL3 secretion on the differentiating action of LH was verified,
because concomitantly with pubertal activation of LH secretion, INSL3 concentrations
began to rise, and those boys treated with the aromatase inhibitor Lz who developed
hypergonadotropic hyperandrogenism (Hero et al. 2005) had significantly higher INSL3
levels than did Pl-treated boys. It was also clear that the positive relationship between
LH and INSL3 was sustained in healthy boys throughout puberty; neither the present
study nor previous studies have shown any negative feedback regulation by INSL3 on
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LH secretion although the gene for the INSL3 receptor LGR8 is expressed in the
pituitary (Bay et al. 2005; Bay et al. 2006; Ferlin et al. 2006; Foresta et al. 2004; Hsu et
al. 2002).
In the KS boys, after their initial normal rise in serum INSL3 concentrations at
onset of puberty, this secretion did not increase in a similar fashion as in the healthy
boys, despite KS boys’ high LH concentrations. Thus, it seems that in KS boys, Leydig
cell function remains during puberty within the low-normal range, as indicated by both
INSL3 and testosterone levels. The impact of low INSL3 levels during puberty and
adulthood is difficult to estimate, since the precise role of INSL3 in adult men is
unknown. At least in theory, because of the antiapoptopic effect of INSL3 on germ cells
(Kawamura et al. 2004), suppression of INSL3 secretion may to some extent reduce
the number of germ cells and hence impair fertility. The finding of LGR8 expression in
meiotic and particularly in postmeiotic germ cells, and in Leydig cells but not in Sertoli
or peritubular cells, supports this hypothesis (Anand-Ivell et al. 2006b). However,
probably not even high INSL3 levels can suppress the massive germ cell apoptosis
occurring in KS subjects during puberty.
The histomorphometric analyses and even more accurately the
immunohistochemical stainings with the spermatogonia marker MAGE-A4 revealed
that in early adolescence as many as 10 of the 14 boys with KS had germ cells in their
testes, but the depletion of these cells accelerated at the onset of puberty. This
presence of germ cells during peripuberty contrasts with findings of Muller et al. (1995),
in which no germ cells were detectable in KS boys beyond the age of 2 years. A
probable explanation is that all the boys in Muller’s study were cryptorchid, whereas
none in our group had any history of testicular maldescent. Ad spermatogonia that
develop postnatally from fetal spermatogonia under gonadotropin and testosterone
stimulation are of fundamental importance for the development of male fertility
(Hadziselimovic and Herzog 2001). In the boys with KS, the fact that the number of
these cells was markedly reduced indicates even before puberty a severely impaired
fertility potential.
Whether germ cell differentiation is delayed in the testes of KS boys, especially
whether germ cells in peripubertal boys still exhibit the features of gonocytes, was
studied by examination of the expression of AP-2g and of OCT-3/4. These are markers
for gonocytes and neoplastic germ cells, and are frequently present in intersex gonads
in children (Hoei-Hansen et al. 2004; Looijenga et al. 2003; Rajpert-De Meyts et al.
2003; Rajpert-De Meyts et al. 2004). The germ cells found in testicular biopsies of our
KS patients were negative for AP-2g and OCT-3/4, but positive for CHK2, a transducer
of DNA damage signals and a tumor suppressor physiologically abundant in its inactive
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form in fetal germ cells and in adult spermatogonia (Bartkova et al. 2001). Germ cells in
adolescent KS boys had thus differentiated from gonocytes into spermatogonia. This
finding was supported by the high expression of MAGE-A4 and of NY-ESO-1, which
appear at protein level in fetal germ cells in the second trimester of pregnancy and
subsequently persist in spermatogonia and to some extent in primary spermatocytes,
especially NY-ESO-1 (Aubry et al. 2001; Bartkova et al. 2001; Rajpert-De Meyts 2006;
Satie et al. 2002). Taken together, these results indicate that in KS, germ cell
differentiation is—at least partially—blocked at the spermatogonium or early primary
spermatocyte stage, since no gonocytes or pachytene spermatocytes were detectable.
It seems that in KS, spermatogonia have difficulty entering meiosis; instead they
proceed to apoptosis, a process that evidently accelerates at puberty, when
differentiation to meiosis normally starts.
An additional rationale for including MAGE-A4 and NY-ESO-1 was that these
two cancer-testis antigens are located on the X chromosome. All spermatogonia in KS
patients and in the controls strongly expressed MAGE-A4, but NY-ESO-1 was
expressed in a more heterogenous manner, as seen previously (Aubry et al. 2001;
Satie et al. 2002). Intensity of staining between KS and controls was identical. Some
SCO tubules expressed MAGE-A4 unspecifically, probably due to leakage of antigens
from degenerating apoptotic spermatogonia. Nor did expression of the Sertoli cell
marker MIC2 between KS subjects and controls differ. MIC2 is a pseudoautosomal
gene located on the X and Y chromosomes (Visfeldt et al. 1999). This identical
expression intensity indicates no impact of a double dose of these X-linked genes; at
this developmental stage one of the gene loci is probably inactivated.
It seems that the presence of germ cells in the testes of adolescent KS boys
correlates with serum levels of FSH, LH, testosterone, inhibin B, and AMH, but the
current series did reveal one exception to this rule: Since the focal nature of the
testicular degeneration process was also demonstrated here, the biopsies in that one
patient (8KS) probably missed areas with tubules containing germ cells.
During puberty the testes of KS boys grow (Salbenblatt et al. 1985; Topper et
al. 1982); this was also observed here. In healthy boys, proliferation of germ cells is
predominantly responsible for pubertal growth of the testes (Cortes et al. 1987; Muller
and Skakkebaek 1983). Since no spermatogenesis was detected beyond the
development of adult spermatogonia, and the number of these cells was low, pubertal
testicular growth in the KS boys was due almost solely to the proliferation of Sertoli and
interstitial cells. This might suggest that the immature Sertoli cells of KS boys are
responding to the pubertal increase in FSH stimulation, as seen in boys with a normal
karyotype. On the other hand, their immature Sertoli Sa and Sb cells were incapable of
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transforming into the adult Sc cell type, and EM revealed degenerating Sertoli cells, a
rare finding in the testes of healthy early pubertal boys. The concept of Sertoli cells in
KS boys regressing after the initial phase of Sertoli cell proliferation is in agreement
with the changes observed in their inhibin B levels.
Secretion of the Sertoli cell hormone inhibin B increases significantly at the
onset of puberty in healthy boys, but thereafter serum levels remain relatively constant
(Andersson et al. 1997; Raivio et al. 1998). Inhibin B concentrations are regulated by
FSH, and during puberty an inverse relationship develops between FSH and inhibin B
(Andersson et al. 1997; Raivio et al. 2000). Inhibin B is thought to reflect Sertoli cell
function during prepuberty and to become germ cell-dependent during midpuberty
(Andersson et al. 1998b). In the KS boys, serum inhibin B levels were normal during
prepuberty and early puberty, but the activation of the pituitary-gonadal axis resulted in
a rapid decrease to unmeasurable levels. A strong correlation appeared between an
increasing testosterone level and suppression of inhibin B and also of the other Sertoli
cell marker, AMH.
 Next came the exploration of the relationship of serum concentrations of
testicular hormones (inhibin B, AMH, and testosterone) to the immunohistochemical
expression pattern. The inhibin a-subunit is expressed at the protein level in Sertoli and
Leydig cells both in fertile and infertile men, but data regarding the location of the bB-
subunit are not as uniform, probably because of differences in tissue processing
(Anderson et al. 1998; Andersson et al. 1998b; Bergh and Cajander 1990; Fujisawa et
al. 2004; Marchetti et al. 2003; Toppari et al. 1998; Vliegen et al. 1993). Three studies
found bB-subunit immunostaining in Sertoli cells even in SCO tubules (Anderson et al.
1998; Fujisawa et al. 2004; Vliegen et al. 1993), whereas two others (Andersson et al.
1998b; Marchetti et al. 2003) found no bB expression in the Sertoli cells of adult men.
Andersson et al. (1998b), studying testicular biopsies of prepubertal boys, detected the
bB in their Sertoli cells. In the present series, all the KS specimens as well as the
controls showed bB-subunit expression to be confined to the Sertoli cells, and also a
weak bB-immunostaining of the Sertoli cells in the morphologically normal testicular
biopsy of one adult control. However, in agreement with all these studies, the bB-
subunit was detected to a varying degree in Leydig cells.
Expression of the inhibin a-subunit in the tubules that contained spermatogonia
was weaker than in SCO tubules, as has been already shown (Bergh and Cajander
1990). For some reason though, this pattern was especially evident in the KS patients.
Overall, the immunostaining of the a-subunit was weaker in older than in younger KS
patients, probably due to the accelerating degeneration of the Sertoli cells. A sign of
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this degeneration process may also be the aberrant nuclear expression of the a-
subunit in the Sertoli cells. Even when serum inhibin B was unmeasurable, both
subunits were expressed in the Sertoli cells, suggesting that in KS, inhibin B synthesis
is altered.
At puberty, AMH expression in Sertoli cells is down-regulated concomitantly
with the appearance of meiotic germ cells and with up-regulation of the androgen
sensitivity of the Sertoli cell, both being features of the final maturation of the Sertoli
cells (Rajpert-De Meyts et al. 1999; Rey et al. 1993; Sharpe et al. 2003). It has been
proposed that the dramatic suppression of AMH production requires meiotic entry in
spermatogenesis (Al-Attar et al. 1997). However, the current study confirmed that the
absence of germ cells did not prevent down-regulation of AMH during puberty, as has
been already shown (Rajpert-De Meyts et al. 1999). But the KS boys showed a delay in
disappearance of AMH expression that may be explained in part by the lack of
influence of meiotically dividing germ cells, as suggested Al-Attar et al. (1997), and in
part by hypoandrogenism (Rey et al. 1993). Furthermore, the Sertoli cells did not
differentiate uniformly, as shown by their heterogeneous expression pattern, a pattern
especially pronounced in the older KS boys.
In normal individuals, AR expression first appears in Sertoli cell nuclei just
before the onset of puberty but before final maturation of the Sertoli cells,
concomitantly with rising concentrations of FSH and testosterone (Sharpe et al. 2003).
Expression of AR in the adult human testis, in order from strongest to weakest, occurs
in Sertoli cells, peritubular myoid cells, smooth muscle cells of the blood vessels, and
finally in Leydig cells (Suarez-Quian et al. 1999). In a study of adult cryptorchid testes,
focal absence of AR expression in Sertoli cells correlated with a lack of local
spermatogenesis, and the intensity of AR staining in Sertoli cells diminished as a
function of severity (Regadera et al. 2001). In another study of AR expression in the
testes of subfertile men, no differences were apparent between subjects as related to
severity of conditions (Van Roijen et al. 1995).
A study of one KS patient has detected AR expression in the nuclei of Sertoli
and peritubular cells, but in contrast to healthy men, his Leydig-cell AR expression was
located in the cytoplasm (Kotula-Balak et al. 2004). In the XXY mouse,
immunoexpression has been nearly absent from the Sertoli cells and localized to the
cytoplasm of the Leydig cells (Lue et al. 2005). In the absence of androgens, AR is
located in the cytoplasm (Gasc and Baulieu 1986). In the KS boys, AR expression in
Sertoli-cell cytoplasm and the smaller proportion of Sertoli cell nuclei expressing AR
may be attributable to their low-normal testosterone levels. In agreement with the
earlier studies (Kotula-Balak et al. 2004; Lue et al. 2005), cytoplasmic staining of
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Leydig cells appeared in the older KS boys, probably as a sign of impaired function of
their hypertrophied Leydig cells, as also indicated by their high serum LH levels and the
leveling-off in their serum testosterone and INSL3 levels. No difference appeared,
however, between the KS boys and their controls in AR immunoexpression in Leydig
cell nuclei, nor were any constant differences evident between tubules containing
spermatogonia and SCO tubules, a finding demonstrated also in one study of
cryptorchid men (Regadera et al. 2001).
The present study found that genetic features of the X chromosome influence
the onset and progression of puberty and the process of testicular degeneration.
However, because the patients in this study were diagnosed in childhood because of
their speech delay and behavioral problems (13 of 14), the present study may include
ascertainment bias; phenotypic features may differ between totally unselected cohorts
of patients diagnosed prenatally or in patients diagnosed in adulthood because of
infertility. Earlier studies have shown that the supernumerary X chromosome is
paternal in 40 to 60% and maternal in 40 to 60% of KS cases (Iitsuka et al. 2001;
Lanfranco et al. 2004; Simpson et al. 2003; Thomas and Hassold 2003), while in the
present study the percentages were 21% paternal (n=3) and 79% maternal (n=11).
Here, the three subjects with a paternal additional X chromosome showed later
onset and slower progression of puberty, but showed no differences in body
composition. Other studies (Jacobs et al. 1988; Lorda-Sanchez et al. 1992; Zinn et al.
2005) have suggested that parental origin of the extra X chromosome has no evident
effect on the phenotypes of KS males. In the first of these studies, this view was based
on the finding of a similar proportion of maternally and paternally derived cases among
subjects diagnosed either prenatally and as newborns, or in adulthood because of
signs of hypogonadism; no phenotypes were studied (Jacobs et al. 1988). The second
study found no significant differences in a number of clinical features, including clinical
signs of hypogonadism and including psychosocial problems discovered by a
questionnaire, between KS patients with a maternal vs. paternal extra X chromosome
(Lorda-Sanchez et al. 1992). The third study found that the parental origin of the
supernumerary X chromosome had no impact on anthropometric and physical findings
(Zinn et al. 2005). In contrast, Stemkens et al. found in their study of 61 KS males aged
2 to 56 years (23.6 ± 15.2), many of whom were on androgen substitution therapy,
increased body size and more motor impairment and speech / language problems in
the paternal X group (Stemkens et al. 2006).
The conclusions of the current study were based not only on anthropological
findings, but also on measurements of serum reproductive hormone levels. Zinn et al.
(2005) measuring FSH, LH, testosterone, and E2 concentrations in their subjects aged
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0.1 to 39 yr, found no differences in testicular function between the maternally and
paternally derived cases. This and the other studies (Jacobs et al. 1988; Lorda-
Sanchez et al. 1992; Stemkens et al. 2006) were, however, cross-sectional, whereas
the present study was longitudinal, and in the present series the phenotypic differences
became apparent during follow-up.
It has been suggested that X chromosome inactivation patterns, especially
skewed X inactivation, influence KS phenotypes (Iitsuka et al. 2001), but to date no
study has thoroughly evaluated the impact of skewed X inactivation. In the study by
Zinn et al. (2005) two subjects showed skewed X inactivation, but no association with
phenotypic features, nor did Stemkens et al. (2006) find any differences. This aspect
was not evaluated in the study by Zitzmann et al. (2004), who had five individuals with
skewed X inactivation in their cohort of 77 adult KS males. Similarly, in the current
study no differences were evident between the two boys with skewed X inactivation
and the other 12 boys.
Isodisomy may lead to a double dosage of some harmful genes which escape
X-inactivation. The present study and the 2005 study by Zinn et al. found no impact on
the KS phenotype, but Lorda-Sanchez et al. (1992) found some minor differences in
the prevalence of some clinical features between KS subjects with X chromosomes
originating in MI and MII; their small number of subjects did not allow any statistical
analysis.
The AR gene located on the X chromosome may play a particular role in the
differences in KS phenotype. However, only one study has found a clear impact of the
CAG repeat length of the AR on the KS phenotype. Zitzmann et al. (2004) found a
positive correlation with body height and presence of gynecomastia, but an inverse
association with bone density, testicular volume, and response to androgen
substitution, and even with social status (Zitzmann et al. 2004). In the study by Zinn et
al. (2005) the only parameter investigated that was associated with CAG repeat length
was penile length; the correlation was inverse. Stemkens et al. (2006) found, however,
no clear pattern of correlation with physical features or developmental problems. In the
present study, those KS boys with a longer CAG repeat showed a later onset and
slower progression of puberty and a slower testicular degeneration process, findings in
agreement with diminished AR response to androgens when the AR gene has a longer
CAG repeat. This also suggests that androgens may play a role in initiating this
degeneration process. The finding of lower AR activity with a slower testicular
degeneration process supports this hypothesis.
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SUMMARY AND FUTURE PERSPECTIVES
This study confirmed that KS boys have sufficient testosterone levels to allow normal
onset and progression of puberty. However, although serum testosterone levels
remained within the low normal range, the results indicate development of a relative
testosterone deficiency from midpuberty onwards. At tissue level, adequate androgen
action was suggested by normal pubertal changes in serum SHBG and PSA. On the
other hand, an increased incidence of gynecomastia, higher leptin levels, plateauing of
INSL3 levels, and exaggerated responses to GnRH stimulation indicate a relative
androgen deficiency. This is also in agreement with the results from the
histomorphometric and immunohistochemical analyses: Leydig cell hyperplasia and
fibrosis of the interstitium developed with age, and altered immunoexpression of AR
indicated diminished androgen action.
During minipuberty KS infants have lower testosterone levels than do healthy
infants (Lahlou et al. 2004; Ross et al. 2005), so one proposal is that KS subjects may
benefit from testosterone supplementation during the first 2 to 3 months of life,
although we still lack evaluation of the role of minipuberty as a predictor of testicular
insufficiency in KS. In the present study, no marked androgen deficiency appeared in
prepubertal and pubertal KS boys; consequently, androgen supplementation does not
seem necessary before midpuberty. However, studies regarding the efficacy of early
androgen substitution on the classical symptoms of KS, and on its somatic,
neurodevelopmental, and psychosocial outcome, are necessary. These studies should
be placebo-controlled to determine what role androgen deficiency plays in exacerbating
the 47,XXY phenotype. All the characteristics of the KS phenotype cannot be ascribed
to the relative hypogonadism; other factors such as the excess of X-chromosome
genes probably also have some impact.
Successful TESE-ICSI for men with nonmosaic KS resulting in the delivery of
healthy children was first reported in 1998 (Palermo et al. 1998). The same group
seven years later reported a sperm retrieval rate of 72% per TESE attempt, and once
sperm was obtained, ICSI resulted in pregnancy in 46% of cycles (Schiff et al. 2005).
This high retrieval rate may be due to preoperative treatment; most of the patients
received an aromatase inhibitor or a combination of hCG and aromatase inhibitor to
enhance intratesticular production of testosterone. Furthermore, their observation that
sperm retrieval rate appeared to be lower (20%) in men who previously received
exogenous androgens (Schiff et al. 2005), may argue against the routine treatment of
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KS males with testosterone. In fact, testosterone treatment causes a marked inhibition
of spermatogonial maturation (McLachlan et al. 2002). The concern for maintenance of
fertility potential in young KS men must be balanced with the potential benefits of
testosterone replacement.
Cryopreservation of semen samples containing very low numbers of
spermatozoa from KS boys in early puberty is possible and should be offered to
appropriate patients before the start of testosterone supplementation. The current
study, however, showed a marked acceleration of germ cell depletion at the onset of
puberty, so the expected success rate is exceedingly low, especially when taking into
account the ability of boys to provide semen samples during early puberty. Another
option if the biopsy sample contains haploid germ cells would be TESE. The possible
future use of cryopreserved testicular samples containing spermatogonia, but not more
mature germ cells, for infertility treatments would require in vitro maturation of
spermatogonia into mature spermatozoa or at least into late / elongated spermatids.
Recent studies indicate that human testicular tissue can be cultured for at least up to 3
weeks without essential loss of spermatogonia (Larsen et al. 2002; Sousa et al. 2002).
Early results also suggest that meiosis and spermatogenesis may resume under
culture conditions, yielding normal spermatids with some fertilizing potential (Sousa et
al. 2002). However, at present this option for fertility preservation in boys before
spermarche remains entirely experimental.
Mechanisms leading to depletion of germ cells start early in life, resulting in a
decreased fertility potential even before puberty. This study also showed by several
means that the testicular degeneration process accelerates at the onset of puberty.
Whether the defect in the 47,XXY testis is intrinsic to germ cells or is due to inability of
the Sertoli cells to support normal germ-cell development is unknown. Furthermore, we
do not know whether the Leydig cell failure is part of a response to germ cell depletion /
Sertoli cell injury or whether specific characteristics are inherent in the failure that are
intrinsic to Leydig cells. The current study indicates that androgens may play a role in
initiating the degeneration of the seminiferous tubules, and that AR polymorphism may
play a role in pathogenesis of gonadal failure. The molecular mechanisms behind the
testicular degeneration process in KS have remained elusive and require further
research.
 Genetic features of the X chromosome appear to play a part in modulating KS
phenotypes. The present study has shown that parental origin of the supernumerary X
chromosome and the length of the CAG repeat of the AR gene influence pubertal
development. Conclusions should, however, be drawn with caution because of the
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small number of patients in this and previous studies. Further studies including a larger
number of subjects are therefore needed to confirm these preliminary results
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